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Heme is an essential cofactor in numerous proteins, but is also cytotoxic.  Thus, directed 
pathways must exist for regulating heme homeostasis. C. elegans is a powerful genetic 
animal model for elucidating these pathways because it is a heme auxotroph. Worms 
acquire dietary heme though HRG-1-related importers, and intestinal export was 
demonstrated to be mediated by the ABC transporter MRP-5. Loss of mrp-5 results in 
embryonic lethality. Although heme transporters have been identified, there are 
significant gaps in our understanding for the heme trafficking beyond HRG-1 and MRP-
5. To identify additional components, we conducted a forward genetic screen utilizing the 
null allele mrp-5(ok2067).  Screening of 160,000 haploid genomes yielded thirty-two 
mrp-5(ok2067) suppressor mutants. Deep-sequencing variant analysis revealed three of 
the suppressors are subunits of adapter protein complex 3 (AP-3). We now seek to 
identify mechanisms for how adaptor protein deficiencies bypass a defect in MRP-5-
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Chapter 1: Literature Review 
Introduction 
 Heme is a protein prosthetic group of fundamental biological importance. It 
serves as a critical component in the activity of a diverse set of proteins, whose functions 
include oxidative metabolism (cytochrome c oxidase), gas transport (globins), xenobiotic 
detoxification (GSTs), gas sensing (NOSynthase, guanylate cyclases) and microRNA 
processing (DGCR8).1-3 Heme consists of an organic tetrapyrrole ring with iron 
coordinated at the center, where each pyrrole is joined at the alpha position by methine 
bridges1. The iron coordinated by heme can undergo reduction or oxidation between the 
ferric and ferrous states. Proteins possessing heme as a cofactor are then able to harness 
this property to mediate redox reactions for various substrates. The use of heme in this 
capacity evolved early in biology, evidenced by the highly conserved cytochromes used 
in oxidative phosphorylation, critical for efficient synthesis of ATP.4 
 Many of the properties which make heme biologically essential concurrently 
manifest in cytotoxicity.5 By itself, iron can generate reactive oxygen species (ROS) 
which has been shown to cause oxidative damage to proteins, lipids, and nucleic acids. 
Heme-iron maintains these properties, and heme’s hydrophobic tetrapyrrole ring 
increases relative cytotoxicity by its tendency to insert into and intercalate between lipid 
bilayers and bind to many proteins non-specifically1,3,6-8. 
Arguments for Intracellular Heme Trafficking 
 In most metazoans, heme is synthesized by the well characterized eight-step 
Shemin Pathway. It begins in the mitochondria with the condensation of succinyl CoA 
and glycine by ALAS to form δ-aminolevulinic acid (ALA). ALA is then converted 





the mitochondrial IMS, CPgenIII undergoes two more enzymatic reactions which results 
in Protoporphyrin IX (PPIX). The final insertion of iron into PPIX results in the release 
of heme b, the most abundant heme, into the mitochondrial matrix.1,2 
 Heme is synthesized de novo in the mitochondrial matrix, while proteins which 
require heme as a prosthetic group reside in most subcellular compartments. This 
necessitates the intracellular transport of heme from the mitochondrial matrix to other 
compartments for incorporation into hemoproteins. Due to inherent cytotoxicity, 
organisms have likely evolved mechanisms to tightly regulate heme trafficking in order 
to avoid spurious cell damage. Although heme synthesis is well characterized, the 
pathways underlying heme trafficking are relatively poorly understood.1 
Arguments for Intercellular Heme Trafficking 
 While intracellular heme trafficking is implied by the necessity for traversing 
intracellular membranes, several lines of experimental evidence suggest that pathways for 
the intercellular transport of heme are utilized in higher vertebrates. First, acute 
intermittent porphyria (AIP) is a human disease which is due to deficiency in 
hydroxymethylbilane synthase (the third enzyme in the Shemin Pathway) which results in 
an overproduction of the upstream heme synthesis intermediates aminolevulinic acid 
(ALA) and porphobilinogen (PBG).9 The most common treatment for an acute attack and 
prevention of recurrent attacks is intravenous infusion of heme10; either as heme-
albumin11, heme arginate, or lypholized hematin.9 Infusion of heme acts to repress 
ALAS, attenuating accumulation of ALA and PBG9. It has also been shown to replete 
regulatory heme pools and restore activity of liver hemoproteins11. These observations 





 Another set of striking observations emerge in the phenotypes of mutant animals 
where the heme synthesis pathway is genetically disrupted. In mice, deletion in 
ferrochelatase  (the final enzyme in the heme synthesis) is unsurprisingly embryonic 
lethal; however, homozygous mutants survive until at least E3.512, indicating that 
developing embryos can access maternal heme.2 Similarly, mutation in zebrafish 
protoporphyrinogen oxidase (ppox) results in embryonic lethality, but some mutants 
survive until approximately 27 days post-fertilization13, implying maternal deposition of 
heme is sufficient for early embryonic development.2 
 Finally, polarized Caco-2 cells (epithelial colorectal adenocarcinoma cells) are 
capable of transporting hemin from the apical to basolateral side14, raising the possibility 
that this process may also occur in vivo for delivery of heme to circulation, where it is 
available to peripheral tissues.2 
Components of Prokaryotic Heme Trafficking 
 Despite the challenges associated with the identification of factors mediating the 
trafficking of heme, significant advancements have been made in several traditional 
model systems. Bacteria represent a simplistic system for trafficking studies without the 
confounding factors of inter-organelle transport. Bacterial heme uptake systems have 
been relatively well characterized. They tend to be robust due to the fact that bacteria 
generally live in iron restricted environments15, thus heme represents a significant source 
of iron.16 Variations of two common heme uptake systems exist in many gram-negative 
bacteria, and are usually clustered into iron-regulated operons.17 The first involves 
binding of heme or hemoproteins by an outer membrane (OM) receptor (HemR) and 





transport protein (HemT) delivers heme to cytoplasmic membrane ABC transporters 
(HemU, HemV) for translocation into the cytosol. The second uptake pathway involves 
secretion of a hemophore (HasA) into extracellular space where it binds heme and 
delivers it to an OM receptor (HasR); once in the periplasm, heme follows the pathway 
previously described to traverse the plasma membrane. Once in the cytosol, heme is 
degraded by heme-oxygenase like enzymes (HemS) which may also function as a 
chaperone.16,17 
Components of Unicellular Eukaryotic Heme Trafficking 
 Heme uptake systems in simple unicellular eukaryotic systems such as yeast are 
poorly defined relative to prokaryotes. Although the budding yeast S. cerevisiae lacks a 
robust heme uptake system, the pathogenic yeast C. albicans efficiently utilizes 
exogenous heme.19 Genome wide screening in C. albicans identified two genes involved 
in heme uptake: RBT5 and RBT5120. Both are GPI-anchored proteins which localize to 
the plasma membrane and are necessary for receptor mediated endocytosis of free heme 
and hemoglobin, respectively. Once endocytosed, heme is delivered to the vacuole and 
catabolized.16,21 
Components Mammalian Heme Trafficking 
 Although the evidence for intercellular heme trafficking in mammals is not 
widely recognized, it is well established that exogenous heme is imported from dietary 
sources present in the intestinal lumen.22 Iron absorption is poor in the small intestine due 
to the fact that under conditions present therein it is readily oxidized and forms insoluble 
complexes.16 Thus it has been estimated that although heme-iron makes up one third of 





importers have been identified; HRG-1 was identified first by its ortholog in C. elegans, 
and will be discussed further in later sections. The other heme importer, Hcp1 was 
identified using expression analysis in mice.24 However, subsequent analysis 
demonstrated that while it does import heme (Km ≈ 125 µM), it transports folate with 
much higher affinity (Km ≈ 1.3 µM), rendering a physiological role for this transporter 
uncertain.25 
 Similarly, heme export has been recognized irrespective of a role in intercellular 
trafficking due to the fact that heme efflux represents a viable mechanism for attenuation 
of heme hyper accumulation in cells. The first recognized heme exporter, FLVCR, was 
serendipitously identified in cats. Although it was a predicted member of the major 
facilitator superfamily of secondary permeases based on homology, its physiological 
substrate was unknown.26 FLVCR acts as the cell surface receptor for the retrovirus feline 
leukemia virus, subgroup C (FeLV-C).26 When infected, felines develop profound 
anemia, exhibit an arrest of erythropoiesis, and feline embryonic fibroblasts 
hyperaccumulate heme.27 Since FeLV-C envelope surface unit protein was shown to have 
a dominant negative effect on FLVCR28, it was postulated these phenotypes may be due 
to a loss of function of FLVCR.26 Ectopic expression of FLVCR in renal epithelial cells 
reduced cellular heme levels, and was capable of inducing export of radiolabeled heme 
and the fluorescent heme analog Zinc Mesoporphyrin (ZnMP) in renal epithelial and 
K562 cells, suggesting that FLVCR is capable of heme efflux.16 FLVCR1 knock-out 
mice lacked definitive erythropoiesis, and died in midgestation.29 FLVCR1 was also 
necessary for export of heme-iron from bone marrow derived macrophages.29 Subsequent 





fractionation showed that FLVCR1a localizes to the plasma membrane, while FLVCR1b 
lacks the first exon and localizes to the mitochondrion.30 Deletion of the first exon did not 
result in anemia, but siRNA against FLVCR1b impaired erythroid differentiation, 
implying that loss of FLVCR1b but not FLVCR1a is responsible for the observed 
erythropoietic defects of FLVCR possibly by playing a role in mobilizing synthesized 
heme from the mitochondria.22,30 FLVCR2 has been proposed to act as a heme importer, 
but rigorous studies exploring its potential role have not been conducted.31 
 Given heme’s capacity for ROS generation and intercalation into lipids, direct 
chaperoning of heme by heme-binding proteins has long been proposed in sequestration 
of heme for storage, or to mediate its delivery to transporters as a mechanism to prevent 
cytotoxicity associated with free heme.16 Demonstration of heme-binding itself is not 
convincing given that heme has been shown to associate with proteins non-specifically.1  
The Need for an Animal Model: Enter C. elegans 
 Although previous efforts have identified many mechanisms capable of 
trafficking heme, a major shortcoming has been the failure to adopt an appropriate system 
for targeted genetic screening. Instead, progress has often relied on serendipitous 
discovery exemplified by the finding of FLVCR. A classic approach to pathway 
discovery is to change a system’s environmental availability for a substrate and then 
examine how the system is adapting to maintain homeostasis. For heme, this has been 
difficult to conduct as most model systems are capable of heme synthesis, and upon heme 
challenge it is difficult to differentiate between components contributing to trafficking 





this has many pleiotropic effects making the identification of changes specifically 
associated with heme trafficking problematic. 
 A potential model system emerged with the finding that Caenhorabditis elegans 
lacks enzymes necessary for heme synthesis rendering them heme auxotrophs.32 This 
necessitated that worms take heme up from the diet and into enterocytes. Since heme is 
required in a wide range of fundamental cellular processes already described, it also 
implies that dietary heme taken up in the intestine must be made available to all extra-
intestinal tissues. Thus components regulating the trafficking of heme must coordinate 
the uptake of heme into the intestine, its intracellular trafficking and eventual export from 
the intestine, as well as its uptake and utilization by all extra-intestinal tissues. This 
makes C. elegans uniquely suited animal model for elucidating pathways that control 
heme trafficking. Additionally, normal heme trafficking would be required for C. elegans 
viability. Loss of a vital component of the heme trafficking pathway could be lethal, an 
excellent genetic readout for conducting forward genetic screens. 
 Among subsequent efforts to identify functional components of heme uptake, a 
microarray study was conducted on worms grown axenically in low, optimal, and high 
heme. This approach identified 288 genes whose expression was changed ≥1.6 fold 
across the three conditions and subsequently classified as heme responsive genes (hrg).33 
HRG-1 and its Paralogs  
 Proof of concept emerged with the identification of the first bona fide, conserved 
heme importer hrg-1.1 Both C. elegans and human HRG-1 are capable of inducing heme 
dependent current in Xenopus laevis oocytes implying a direct capability to bind and 





as both C. elegans and human HRG-1 co-localize in human cell lines. Morpholino 
knockdown of hrg-1 in zebrafish results in morphological defects including impaired 
erythropoiesis, and these phenotypes are rescued by heterologous expression of C. 
elegans hrg-1.34 The discovery of this conserved heme importer in C. elegans validated 
the approach of using worms as a model for discovery of novel components and 
pathways of heme trafficking which may be conserved in higher order metzoans. 
 In C. elegans, hrg-1 has three paralogs: hrg-4, hrg-5, and hrg-6.34 Low heme 
transcriptionally upregulates hrg-1 and hrg-4, and both are down regulated in high heme. 
In contrast, hrg-5 and hrg-6 remain transcriptionally active at high heme.34,35 HRG-
1::GFP localizes to intracellular vesicles, while HRG-4::GFP is localized exclusively to 
the apical membrane of enterocytes.35,36 Feeding of a toxic heme analog, gallium 
protoporphyrinIX (GaPPIX), results in embryonic lethality in the progeny of exposed 
adults.32 Interestingly, RNAi of hrg-4 but not hrg-1 reduced toxicity associated with 
GaPPIX exposure, indicating hrg-4 function may be more critical for uptake of 
porphyrins.34 Pulsing with Zinc Mesoporphyrin (ZnMP), a fluorescent heme analog, 
resulted in accumulation of ZnMP in intracellular vesicles within the intestine. Treatment 
with RNAi against hrg-4 resulted in a loss of ZnMP accumulation, while RNAi of hrg-1 
resulted in an increase of ZnMP accumulation.34 Interestingly, HRG-1::GFP showed 
significant co-localization with ZnMP vesicles.36 These data support a model where 
HRG-4 acts to mediate heme uptake at the apical membrane, while HRG-1 mediates 
import from an intracellular compartment. In HeLa cells and yeast, HRG1 co-localizes 
with V-ATPase subunits37 and the interaction of HRG1 with heme in vitro requires low 





These data indicate that the identity of HRG-1 compartments is likely acidified organelles 
of the endolysosomal system.34,38 Loss of either hrg-1 or hrg-4 is not lethal, and loss of 
both results in only a mild growth phenotype; thus it seems that intestinal heme uptake in 
C. elegans is highly redundant. This also means that screening for suppression of loss of 
intestinal import may not be ideal since it would require scoring a non-lethal phenotype. 
 The characterization of hrg-1 also led to the construction of a heme sensor strain 
(IQ6011), consisting of a transcriptional fusion of the hrg-1 promoter with GFP.34 In this 
strain, intestinal GFP levels are inversely correlated with heme availability.34,39 
Subsequently, a genome-wide RNAi screen knocked down 18,533 genes (93% of the 
genome)40 by RNAi in IQ6011 sensor worms and 177 genes resulted in significant 
alteration of Phrg-1::GFP activity.
41 The identification of hrg-1 as a conserved heme 
importer34,36,42 validated C. elegans as an invaluable model organism for the discovery of 
novel components of heme trafficking relevant in higher organisms. 
HRG-3 
 HRG-3 was identified as an intercellular heme chaperone in C. elegans.43 The 
previously described microarray study indicated hrg-3 to be upregulated >70 fold in low 
heme.43 Null mutants in hrg-3 have no overt phenotypes in normal growth conditions, but 
in conditions where environmental heme is relatively low, hrg-3 mutant progeny 
exhibited embryonic lethality and early larval arrest.43 Fitting with this observation, 
subsequent qRT-PCR demonstrated that hrg-3 transcript is only detectable in low heme 
conditions (≤6 µM heme in axenic mCeHR-2). A transcriptional GFP fusion indicated 
that hrg-3 is expressed in the intestine, with the highest signal in the anterior intestine. 





primarily to extra-intestinal tissues including the uterus, coelomocytes (extra-intestinal 
macrophage-like cells in the pseudocoelom), and gonadal sheath cells when driven either 
from its own promoter or the constitutive, intestinal specific promoter vha-6. These 
results show that HRG-3 is secreted from the intestine and taken up into extra-intestinal 
tissues.43  
 Subsequent spectroscopic analysis demonstrated that HRG-3 binds heme with a 
stoichiometry of two parts HRG-3 to one part heme regardless of heme-iron’s oxidation 
state43, fitting with later studies showing that HRG-3 dimerizes, and histidines are 
important for dimerization and heme binding.44 Analysis of hrg-3 mutants expressing a 
non-integrated HRG-3 transgene where transgene transmission to progeny was ~40% 
indicated that in low heme conditions, P0 lacking the transgene laid progeny exhibiting 
either embryonic lethality or larval arrest; however, P0 expressing the rescue transgene 
yielded progeny without defect, regardless of F1 segregation of the rescue transgene.
43 
These experiments indicate that in heme limiting conditions, HRG-3 is secreted and taken 
up by extra-intestinal tissues. Critically, it mobilizes maternal heme to progeny.43  
MRP-5 
 While hrg-3 demonstrated a pathway of intestinal heme efflux, several lines of 
evidence indicated that hrg-3 independent pathways must exist. The fact that null mutants 
lack a phenotype in normal growth conditions and that hrg-3 is only transcriptionally 
active in very low heme43 imply the necessity for a pathway mediating intestinal efflux 
under heme sufficient growth conditions. An early candidate appeared in the form of 
mrp-5, an ABC transporter homologous to human CFTR. Previously described 





bioinformatic analysis showed that its putative promoter contains the 23bp heme 
responsive element responsible for hrg-1 heme dependent regulation.39,40 Subsequent 
RNAi against 288 hrgs in IQ6011 (Phrg-1::GFP) demonstrated that loss of mrp-5 results 
in a perceived heme deficiency which persisted even with high heme supplementation 
(≥500 µM).40  
 Interestingly, RNAi against mrp-5 results in embryonic lethality, which can be 
rescued by heme supplementation. RNAi against seven other mrp genes (besides mrp-5) 
and five putative homologs of FLVCR in C. elegans did not phenocopy mrp-5, indicating 
that mrp-5 plays a unique and critical role in C. elegans heme homeostasis.40 Tissue 
specific RNAi demonstrated that although mrp-5 appears to be transcribed in several 
tissues, only intestinal loss of mrp-5 recapitulates the lethality phenotype, indicating that 
a crucial site of mrp-5 activity was in the intestine.40 An intestinal MRP-5::GFP fusion 
protein localized to the basolateral membrane as well as intracellular compartments.40 
RNAi against mrp-5 also resulted in an increased accumulation of ZnMP in intestinal 
vesicles, as well as resistance to GaPPIX toxicity, suggesting that mrp-5 could be 
exporting porphyrins from the intestine. 
 Although direct heme binding by MRP-5 has not been demonstrated, 
heterologous expression of MRP-5 decreased viability of the heme synthesis deficient 
yeast strain Δhem1, and reporter assays indicated MRP-5 expression results in a re-
partitioning of heme from the cytoplasm to intracellular organelles.40 This implies that 
MRP-5 either directly transports heme or a substrate that influences cellular heme. 
Mammalian MRP5 has also been shown to promiscuously transport a range of substrates 





unclear. In zebrafish, morpholino knockdown of mrp-5 resulted in anemia and reduced 
blood cell formation.40 However, Mrp5 knockout mice have no overt phenotypes.40 In 
MEFs, Mrp5 localized to the plasma membrane (co-localized with WGA), Golgi (co-
localized with galactoysltransferase), and early/recycling endosomes (co-localized with 
Rab4, Rab5, Rab9, and Rab11), raising the possibility that in mammals MRP5 may 
mediate heme transport into intracellular organelles.39,40,46 These data indicate that while 
lethality phenotypes are not conserved between C. elegans and higher vertebrates, the 
mechanism for heme trafficking may be conserved. 
 The fact that loss of mrp-5 can be suppressed by supplementation of dietary heme 
implies the presence of another lower affinity pathway for heme export from the 
intestine. The severe embryonic lethality associated with loss of mrp-5 in normal growth 
conditions presented an easy to score phenotype for a forward genetic suppressor screen. 
Trafficking of Heme Homeostatic Components  
 Several of the identified proteins important in heme homeostasis are 
transmembrane proteins, such as importers HRG-1 and its paralogs, and the exporter 
MRP-5. Although the signals required for their normal trafficking have not been well 
studied, maintaining proper localization is critical to their function in partitioning of 
intestinal heme. 
 In silico motif analysis revealed a semi-conserved acidic di-leucine based sorting 
signal at the C-terminus40 (ETDLLI in humans at position 1363, GTDKLI in C. elegans), 
and tyrosine (YRAF in C. elegans at position 172, YRAD in humans)34 and di-leucine 
(ESQPLL in C. elegans at position 178, DISILS in humans) based sorting signals in the 





lack a hydrophobic residue (Ø) in the final position of the tyrosine based sorting motif 
(YLNK, YSNQ, respectively); the HRG-6 sorting signal fits the canonical motif, 
although it is distinct from that of HRG-1 (YGKL).35 Given that tyrosine based sorting 
motifs are generally degenerate in nature, computational analysis is insufficient to 
determine the role of these motifs in membrane sorting.48 With the exception of HRG-1, 
the other paralogs all lack the di-leucine based sorting motif (hrg-4: TASEDG; hrg-5: 
ILKSEI; hrg-6: KSIIHP). The discrepancies between sorting signals in HRG-1 and its 
paralogs fits with the purely apical localization seen in the intestine for HRG-4 and HRG-
6 and supports that the endolysosomal localization of HRG-1 is directed by recognition 
of these motifs, particularly its acidic di-leucine based sorting motif.34-36 
 Sorting events require recognition of these cytosolic sorting signals by trafficking 
adaptors; adaptor binding mediates the formation and budding of coated vesicles 
containing the specified cargo. Recognition of these sorting motifs is mediated by adaptor 
protein complexes (APs)47, a family of heterotetrameric complexes. In mammals, there 
are currently five APs identified49-51. However, there are only three in C. elegans, D. 
melanogaster, S. cerevisiae, and S. pombe. Thus the extent of functional conservation in 
mammals and other model organisms is uncertain.51,52 Tyrosine based sorting motifs are 
proposed to require µ AP subunit binding, while di-leucine based motifs can bind either µ 
or β AP subunits.47  
 Sorting signals fitting the YXXØ motif (where X is any amino acid and Ø is an 
amino acid with a bulky hydrophobic side chain)53,54 mediate sorting of transmembrane 
proteins to endosomes47, lysosomes47,55, as well as the basolateral membrane of polarized 





heterotetrameric adaptor protein complexes47. Binding to one of the AP complexes then 
specifies a destination compartment for the YXXØ containing cargo.57 The same sorting 
signal being responsible for sorting to distinct destinations raises an issue of specificity. 
However, studies utilizing mammalian orthologs of AP complex µ subunits have 
demonstrated that while the four mammalian µ subunit homologs recognize the YXXØ 
motif, distinctions arise in preference for the identity of “X” or “Ø”.58  
 The conserved tyrosine and di-leucine based sorting signals in the carboxy 
terminus of HRG-1 are likely important for its endolysosomal localization. The acidic di-
leucine based sorting signal in MRP-5 is likely an important factor for its normal 
localization. Recognition of MRP-5’s sorting signal for endocytic recycling is  typically 
AP-2 dependent59, however sorting of cargo with di-leucine based sorting motifs can also 
be influenced by recognition of GGAs which play a critical role in sorting cargo from the 
trans-golgi in mammals47. There are reports of a single ortholog in C. elegans, but the 
extent of their functional conservation has not been explored.60,61 The acidic di-leucine 
based sorting signal of MRP-5 may also mediate its basolateral sorting in polarized 
intestinal cells, a process where recognition of the sorting signal by AP-1 is necessary for 
normal polarized sorting in C. elegans, mice, and zebrafish.62-65 
 Whereas AP-1 and AP-2 play major roles in the trafficking of a large number of 
cargoes, AP-3 seems to mediate the trafficking of a smaller subset of cargoes to lysosome 
related organelles (LROs).51 In mammals trafficking to these compartments are mediated 
by AP-3 as well as BLOC-1 (Biogenesis of Lysosome-related Organelles Complex-1), 
BLOC-2, and BLOC-3. In humans, mutations in these genes result in a Hermansky-





and melanosomes.66-69 In C. elegans, only orthologs of AP-3 and BLOC-1 subunits have 
been identified, and result in aberrant formation of an intestinal specific LRO known as 
gut granules.70,71 Gut granules are characterized by their accumulation of autofluorescent 
and birefringent material72, and are important sites of storage for micronutrients such as 
zinc.73 
Gaps in Knowledge of C. elegans Heme Trafficking 
 Despite the advances in our understanding of heme trafficking pathways in the 
past decade using C. elegans as a model, the identification of many putatively necessary 
components in this pathway have remained elusive (Figure 1).34,40,43,74-76  
 Fitting with the intestinal localization of ZnMP34, work using genetically encoded 
HRP reporters indicated that the in high heme, the intestine continues to accumulate 
heme after heme levels in other tissues saturate 77 and that the intestine may play a role in 
heme storage. However, identification of functional components for heme storage as well 
as an intestinal site of storage has been unsuccessful.  
 Additionally a precise mechanism for intracellular heme chaperoning between 
transporters are unknown. Previous studies have indicated that importers hrg-1 and hrg-4 
transport heme to the cytosol, but how cytosolic heme is delivered to MRP-5 is unknown. 
The intent of this project was to conduct a forward genetic suppressor screen to uncover 
mechanisms by which loss of mrp-5 may be genetically suppressed. Identification of 
these mechanisms may elucidate additional components which directly participate in 







Figure 1: Summary of C. elegans Heme Trafficking 
 A summary of known and unknown components functioning in C. elegans 
intestinal heme trafficking. Dietary heme in the intestinal lumen must be imported and 
stored in the intestine, then exported across the basolateral membrane to supply extra-
intestinal tissues. The importer HRG-4 is localized to the apical membrane and transports 
heme from the intestinal lumen to the cytosol, while the importer HRG-1 transports heme 
from an intracellular compartment to the cytosol. The exporter MRP-5 transports heme 
from the cytosol to the pseudocoelom. In low heme, HRG-3 dimerizes and is secreted 
from the intestine, though the details of its heme acquisition are unknown. ZnMP 
accumulation indicates that heme accumulates in intracellular vesicles, some of which co-





















Chapter 2: Methods 
Growth Conditions 
Worms were maintained at 20 °C in axenic liquid mCeHR-2 media78 supplemented with 
20 µM heme with continuous shaking or on nematode growth medium (NGM) plates 
seeded with OP50 bacteria grown overnight in Luria Broth (LB). NGM plates contained 
3 g/L NaCl, 2.5 g/L peptone, 20 g/L agar, 5 mg/L cholesterol, 0.1 M CaCl2, 0.1 M 
MgSO4, and 25 mM KH2PO4. NGM agar was autoclaved for 45 m, and allowed to cool 
to 60
o 
C in an oven before addition of cholesterol, CaCl2, MgSO4, and KH2PO4. 
NGM Plate Heme Supplementation 
Two approaches were used to supplement NGM plates with hemin chloride, and the 
method used is specified for each assay. One is to directly add hemin chloride to the 
NGM agar following cooling to 60 
o 
C, just before plating. The other is to supplement LB 
Broth used to culture E. coli with hemin chloride. The prior approach is preferred because 
it is difficult to consistently plate the precise volume of agar, thus once LB + hemin is 
absorbed, the effective concentration of hemin may vary. 
Hemin Chloride Prep 
130 mg hemin chloride (Frontier CAS# 16009-13-8) was added to 15 mL of 0.3 M 
NH4OH. Concentrated HCL was added until the solution had a pH of 8.00 (+/- 0.05). The 
solution was brought to 20 mL with 0.3 M NH4OH (pH 8.0) to give a final concentration 
of 10 mM hemin chloride. 
Bleaching 
Worms were collected from plates with 0.1 M NaCl. Washing consisted of allowing 





NaCl. Three washes were conducted to remove bacteria, and finally the worm pellet was 
resuspended in 3 mL 0.1 M NaCl. All downstream steps (except centrifugation) were 
conducted in a sterile laminar flow hood. In a separate tube, 1 mL of 5 M NaOH was 
mixed with 2 mL 5% Chlorox bleach solution. Then, 1.5 mL of the NaOH / bleach 
solution was added to the nematode population. The ratio of worm suspension to 
bleach/NaOH is 2:1; for very large batches of worms, the total volume was adjusted as 
needed. The suspension was intermittently vortexed until the cuticles of gravid worms 
dissolved and the eggs were released, then immediately centrifuged at 800 g for 1 m at 4 
o 
C. The supernatant was aspirated, and 10 mL sterile water was added to the egg pellet 
and vortexed for 5 s. The suspension was centrifuged at 800 g for 1 m at 4 
o 
C. The 
supernatant was aspirated, and the egg pellet was re-suspended in 10 mL sterile water and 
vortexed for 5 s. The suspension was centrifuged at 800 g for 1 m at 4 
o 
C. The 
supernatant was aspirated, and the pellet was resuspended in 5-10 mL M9 salt solution 
(86 mM NaCl, 42 mM Na2HPO4, 22 mM KH2PO4, 1 mM MgSO4 7H2O). The eggs were 
hatched overnight in the M9 solution at 20 ° C rotating at 70 RPM. 
RNAi feeding 
Bacterial cultures consisted of E. coli HT115(DE3) expressing elt-1, elt-2, elt-6 double-
stranded RNA from the Ahringer or Orfeome library and all sequences were verified by 
amplifying regions downstream of the T7 promoter. NGM RNAi plates were prepared as 
described in Growth Conditions except that after cooling and before plating, carbenicillin 
(100 µg/mL), tetracycline (12 µg/mL), and IPTG (476.6 µg/mL) were added to NGM 
agar. Bacterial cultures were prepared with HT115(DE3) grown first overnight in LB 





cultures were diluted (80 µL overnight culture to 1 mL fresh LB carb/tet) and allowed to 
grow for 5.5 h at 37 ° C. NGM RNAi plates were seeded with 5.5 h cultures and dried, 
then allowed to sit at 21° C overnight to allow induction of dsRNA production by IPTG. 
Plates were stored at 4° C for up to a week before use. 
Worm strains 
Worms strains used in this study are listed in Table I. N2, VC1599, RB662, TU3335, 
JJ1271[glo-1(zu391)], glo-2(zu445), GH378[pgp-2(kx48)], were obtained from the 
Caenorhabditis Genetics Center (CGC, USA). 
Ethyl Methanesulfonate (EMS) Mutagenesis Screen 
Adapted from Jorgensen et. Al (2002).79. Synchronized worms were grown axenically in 
mCeHR-2 media in a T-25 flask. Once worms reached the early L4 stage, media was 
moved from the flask to a 15 mL conical tube. The worm suspension was washed three 
times (one wash consists of spinning at 800 g for 5 m, followed by resuspension in 10 mL 
M9). For the final wash, the worm suspension was resuspended in 2 mL M9. In a laminar 
flow hood, 0.1 M EMS was made by adding 20 µL liquid EMS (Sigma #M-0880) to 2 
mL M9 buffer. The solution was gently inverted until EMS dissolved. The 2 mL worm 
suspension and 2 mL 0.1 M EMS was combined for a final volume of 4 mL of 50 mM 
EMS and worm suspension. The 15 mL conical was closed loosely to allow gas 
exchange, and put inside a container in a 20 
o
C incubator rocking at 70 RPM for 4 h. 
Following 4 h 50 mM EMS treatment, worms were washed twice with M9 as described 
above and moved back to a T-25 flask containing mCeHR-2 and allowed to grow. All 





inactivating solution (0.1 M NaOH, 20% w/v Na2S2O3) for at least 24 h, and all EMS 
solution were mixed with equal volume EMS inactivating solution for 24 h. 
ZnMP treatment 
Worms were synchronized as L1s, and placed on 60 mm NGM plates seeded with OP50 
supplemented with 30 µM hemin chloride. Once at the early L4 stage, worms were 
collected from plates by washing off with 0.1 M NaCl, and were washed three times 
(settling worms on ice for 10 m, aspirating the supernatant, then re-suspending in 10 mL 
0.1 M NaCl); following the final wash, worms were re-suspended to a volume ~500 µL. 
ZnMP treatment was carried out 12-well plates containing 2 mL of mCeHR-2 per well. 
Each well contained 1.5 µM hemin chloride, plus either 0 µM or 50 µM ZnMP. Worms 
were moved into wells at a final density of roughly 250 worms/mL. Worms were treated 
O/N (~15hs) at 20 ° C, shaking at 70 RPM. Following treatment, worms were removed 
from wells and allowed to settle on ice for 10 m, then washed twice with 0.1 M NaCl. 
Worms were then allowed to gently shake for 10 m to flush the gut. Worm pellets were 
kept on ice until being mounted for microscopy. Worms were mounted on agar pads and 
treated with 1 mM NaN3 for imaging. 
Mapping: 
 Mapping cross experiment 
Crossing plates consisted of 35 mm NGM plates with a 10 µL spot of OP50 
bacteria seeded in the center of the plate. Heme supplemented crossing plates 
used both 200 µM hemin chloride added in the NGM agar, as well as in the LB 
OP50 culture. The P0 generation consisted of fifteen Hawaiian mrp-5(ok2067/o) 





heme supplemented crossing plate. The inclusion of an mrp-5(+/+) and mrp-
5(ok2067/ok2067) (non-suppressor) were critical controls for downstream 
screening of F2 recombinant lines for mrp-5 suppression. Once F1 progeny were 
laid, P0 were picked off and genotyped to confirm their mrp-5 allele, and their 
respective Hawaiian/N2 backgrounds. Each F1 animal was picked clonally to 24-
well NGM plates supplemented with 200 µM hemin chloride in the NGM. F1 
animals were observed, and the frequency of F1 males was used as a relative 
gauge of mating success. Once F1 hermaphrodites laid F2 progeny, F1 were 
genotyped for N2 and Hawaiian backgrounds as described. Bona fide cross 
progeny (heterozygous for Hawaiian and N2 background) were identified, and 
~300 F2 from true F1 cross progeny were picked out clonally to 24-well NGM 
plates without heme supplementation. F2 animals were allowed to grow and 
subsequently wells were screened for mrp-5 suppression, indicated by 
hatching/growing F3 animals. Around 50 recombinant F2 lines and their F3 
progeny were pooled for sequencing.  
 Genomic DNA Extraction 
Worms were collected from plates with M9; all pipetting of worms was done with 
glass Pasteur pipettes.  Collected worm pellets were washed with 10x volume of 
TE five times to remove bacteria, and aspirated to a final volume of 100 µL. The 
pellet was sonicated with a Bioruptor on high setting, 30 s on, 30 s off for two 15 
minute cycles. Next, 50 µL of Proteinase K (10 mg/mL) was added followed by 
incubation at 65
 o
C for one hour, until the solution was clear. Next, 20 µL of 







30 m. Following incubation, the DNA purified with the Qiagen PCR purification 
kit, and eluted with 30 µL TE. Quantification of DNA was done with PicoGreen 
(ThermoFisher).  
 Library Prep 
Library construction was done with the NuGen Ovation SP+ Ultralow DR kit, 
using 50 ng sheared genomic DNA samples. Library integrity was checked by 
Agilent High Sensitivity DNA Assay Kit.  
 Sequencing 
Sequencing was performed by Harold Smith at the NIDDK Genomics Core on an 
Illumina HiSeq 2500; at least 20x genome coverage (read depth) was obtained for 
each sample to ensure accurate variant calling. In addition to the three suppressors 
analyzed, the two parental strains were also sequenced (The N2; mrp-
5(ok2067/ok2067) pre-mutagenesis strain to allow identification of novel EMS 
induced mutations, as well as Hw; mrp-5(ok2067/ok2067) background which 
contains the paternal contribution for the mapping cross). 
 Sequencing Analysis 
All downstream analyses of the gripped FASTQ files were performed using 
CloudMap80. First, FASTQ files were concatenated for each sample sequenced. 
Variants present in either parental strains [Hawaiian; mrp-5(ok2067/ok2067) 
(paternal strain) or N2; mrp-5(ok2067/ok2067) (pre-mutagenesis strain)] were 
subtracted using “CloudMap Subtract Variants workflow (1 set candidates, 2 sets 
variants to subtract)” workflow published by gm212380 to constrain the set of 





analysis was conducted using the “CloudMap Hawaiian Variant Mapping with 
WGS and Variant Calling workflow” published by gm212380.  
Genotyping 
All genotyping used the same single worm PCR protocol. Single Worm Lysis Buffer was 
prepared as a stock (50 mM KCl, 10 mM Tris-HCL pH 8.3, 2.5 mM MgCl2, 0.45 % NP-
40, 0.45 % Tween 20, 0.01 % Gelatin). Proteinase K was freshly added to lysis buffer to 
the final concentration of 1 mg/mL, and 5 µL of this solution was added to a 0.2 ml PCR 
tube. A worm was added to the lysis buffer in the tube, then placed at 80 °C for at least 2 
h (can be stored at this step), then incubated for 65 °C for one hour, and then 95 °C for 30 
m. For each PCR reaction, 2 µL of lysate was used as a template; if multiple reactions 
were necessary, lysate was diluted with sterile dH2O up to 10 µL. General PCR 
conditions were 2 mM MgCl2, 2 mM dNTPs, and 0.8 µM primers (each). Taq was used 
for polymerization.  
  Reaction steps: 
1. 95 ° C, 2 m 
2. 95 ° C, 30 s 
3. 58 ° C, 30 s 
4. 72 ° C, 90 s 
5. 72 ° C, 10 m 
6. 10 ° C, forever 
Steps 2-4 were repeated for a total of 35 cycles. 






1. 5’ flank mrp-5(ok2067): 5’ – GAT GGC TCA AGA 
AAG GAC ACG – 3’ 
2. 5’ internal mrp-5(ok2067): 5’ – GGT ATT TGT TTC 
ATG CTT CCG TGC – 3’ 
3. 3’ flank mrp-5(ok2067): 5’ – AGC ATG ACT GTC 
AAA AGT GCG – 3’ 
Two PCR reactions were used to genotype the mrp-5(ok2067) 
allele. The first reaction used primers 1 and 3, and yielded a 
1412bp fragment for mrp-5(+) and a 245bp fragment for mrp-
5(ok2067). The second reaction used primers 2 and 3 and yielded a 
327bp fragment for mrp-5(+), and no product for mrp-5(ok2067). 
Below is a summary in tabular form. 
 5’ flank + 3’ flank 5’ internal + 3’ flank 
mrp-5(+) 1412 bp 327 bp 
mrp-5(ok2067) 245 bp no product 
 
o apb-3(ok429) 
  Primers: 
1. 5’ flank apb-3(ok429): 5’ – GAA TTG GAG TGC TGC 
TTG GT – 3’ 
2. 5’ internal apb-3(ok429): 5’ – AAC CGA TTT TAG 





3. 3’ flank apb-3(ok429): 5’ – GCC CGT TTC CTT CAA 
TTA CA – 3’ 
Two PCR reactions were used to genotype the apb-3(ok429) allele. 
The first reaction used primers 1 and 3, and yielded a 1688bp 
fragment for apb-3(+) and a 622bp fragment for apb-3(ok429). 
The second reaction used primers 2 and 3 and yielded a 407bp 
fragment for apb-3(+), and no product for apb-3(ok429). Below is 
a summary in tabular form. 
 5’ flank + 3’ flank 5’ internal + 3’ flank 
apb-3(+) 1688 bp 407 bp 
apb-3(ok429) 622 bp no product 
 
o N2, Hawaiian genotyping for mapping cross 
Protocol for genotyping Hawaiian background from N2 
background by snip-SNPs was adapted from Davis, et. Al.81 
Specifically, an N2 specific snip-SNP on clone T24B8 (CHII at 
position 9,052,466; wormbase ID: snp_T24B8[1]) and a Hawaiian 
specific snip-SNP on clone F56C9 (CHIII at position 7,320,107; 
wormbase ID: snp_F56C9[1]) were used. Described primers81 
were used, and PCR was conducted as described except that 0.4 
µM each primer was used, the annealing temperature was 60 °C 
(step 3), and elongation time was 1 minute (step 4). A 16 µL 





DraI (NEB), 4.3µL sterile dH2O, and 10µL PCR product (directly 
from PCR reaction, no cleanup) was incubated overnight at 37°C. 
Both digested and un-digested (PCR product) products were 
analyzed by 2% agarose gel. The N2 specific snip-SNP 
snp_T24B8[1] reaction produces a 494bp fragment, which upon 
DraI digestion yields 373bp and 121bp fragments. The Hawaiian 
specific snip-SNP snp_F56C9[1] reaction yields a 486bp fragment, 
and upon DraI digestion results in 354bp and 132bp fragments.  
 N2 Hawaiian N2/Hawaiian 
snp_T24B8[1] 373bp + 
121bp 
494bp 494bp + 
373bp + 
121bp 






Assay for RNAi suppression of mrp-5(ok2067/ok2067) lethality 
RNAi was conducted as specified, except that RNAi was conducted for a generation on 
high heme, and the progeny were moved to the same RNAi conditions with no added 
heme. In detail, P0 gravid worms were picked clonally onto RNAi plates with 200 µM 
heme added to the NGM (after cooling, before pouring). The worms were allowed to lay 
eggs (F1) overnight and the P0 gravid worms were picked off. The F1 generation was 





under high heme RNAi conditions. Adult F1 worms were picked clonally onto fresh 
RNAi plates of the same condition, but without added heme. The worms were allowed to 
lay F2 progeny overnight, and then the F1 were removed. Plates were observed until F3 
worms reached adulthood, and then the entire population was analyzed by COPAS 
BioSort (Union Biometrica). 
Combinatorial RNAi  
Combinatorial RNAi was conducted the same as described, except that following 5.5 
hour cultures of HT115(DE3), equal volumes of the two cultures (each containing 
bacteria designed to target a specific gene) were combined, mixed by vortex, then the 
normal volume of combined culture was used to seed the NGM RNAi plates. Worm 
strains used for these experiments all contained the RNAi hypersensitivity mutation lin-
15B(n744).  
Worm Growth Assay 
Populations of bleached and synchronized L1 worms were plated onto 10 cm NGM 
plates without any bacteria seeded. Three L1 worms (P0) were picked into each well of a 
12-well plate. Once gravid F1 worms were observed in the positive control growth 
condition (either vector or vector +Heme, specified in figure description), all populations 
were analyzed as described by ReFLx on a COPAS BioSort (Union Biometrica). 
Transcriptional Reporter under RNAi 
Approximately 40 synchronized L1worms of the indicated strain were placed into each 
well of a 12-well plate. Once gravid, populations were analyzed by ReFLx on a COPAS 
BioSort (Union Biometrica). For each individual event, the integral GFP was normalized 





worm. All of the values for individuals in a given replicate (well) were then averaged, 
and the averages of the three replicates were averaged to give the value for one biological 
replicate. 
ReFLx Analysis by COPAS BioSort (Union Biometrica) 
Worms were washed from plates with ~1 mL M9 and transferred with a 9” glass Pasteur 
pipette to 1.7 mL eppendorf tubes. Worms were allowed to settle on ice for 15 m; the 
supernatant was then aspirated, and an additional 1 mL of M9 was added to the pellet; 
this constitutes one wash. Worm suspensions were washed once more, and then the 
supernatant aspirated to a remaining volume of ~100 µL. These worm suspensions were 
then moved to a well in a 96-well plate. Samples of worm suspension were separated by 
three “blank” wash wells containing M9 only. All hits were filtered for EXT>30 to filter 
out debris. All conditions were tested in triplicate (three individual wells), and the 
arithmetic mean of these constituted one biological replicate. 
Confocal 
Confocal images were taken with a Zeiss LSM710 confocal microscope with a 63x oil 
immersion objective. Autofluorescence was visualized with excitation at 405nm, and 
emission though a DAPI filter. ZnMP and mCherry were visualized with excitation at 
561nm and emission though a rhodamine filter. To calibrate DAPI filter settings for 
visualization of autofluorescence, N2 worms were used. Laser power was set at 1.0 and 
the gain was adjusted until intestinal cells showed autofluorescent punctae just below 
signal saturation. To calibrate rhodamine filter settings for visualization of ZnMP, N2 
worms treated with vehicle (0 µM ZnMP, NH4OH) were used. Laser power was set at 





settings for visualization of HRG-1-mCherry, IQ6112 worms treated with hrg-1 RNAi as 


























Chapter 3: Results 
A system of mrp-5 deficiency 
 The first step towards conducting a forward genetic screen for suppression of 
deficiency of mrp-5 was to identify a system of mrp-5 deficiency which elicited a strong 
lethality phenotype. RNAi mediated knockdown of mrp-5 in the parental generation 
results in heme dependent embryonic lethality in F1 progeny, a phenotype exacerbated for 
embryos laid later (Figure 1). However, RNAi is not a suitable system to conduct a 
forward genetic screen because any gene capable of impacting the RNAi pathway could 
erroneously classified as an mrp-5 suppressor.  
 A deletion allele, mrp-5(ok2067), was already available through the CGC (Figure 
2). The mrp-5 genetic locus is situated on the right arm of the X chomosome, between 
14,945kb and 14,938kb. The mrp-5(ok2067) allele harbors a 1,167bp deletion which 
spans four exons. RT-PCR confirmed that this results in a truncated mRNA with an in 
frame 528bp deletion. Bioinformatic analysis of the truncated mRNA sequence indicated 
that the deletion of 176 amino acids contains three transmembrane domains. Wildtype 
MRP-5 consists of two membrane spanning domains each consisting of six 
transmembrane helices, as well as two ATP Binding Cassettes (ABCs) which must 
physically interact to catalyze ATP hydrolysis, allowing transport of a substrate. 
Topology modeling of the truncated MRP-5 shows that the second ABC would be flipped 
to the opposite side of the membrane from the first ABC, preventing interaction of the 
two cassettes making the truncated protein incapable of ATP hydrolysis. Thus, the 





 In support of the assertion that mrp-5(ok2067/ok2067) worms would show 
phenotypes associated with mrp-5 deficiency, worms homozygous for the deletion allele 
were non-viable, and the deletion was maintained as a balanced heterozygote as the strain 
VC1599. Subsequent isolation of mrp-5(ok2067/ok2067) worms under high heme 
conditions recapitulated heme-dependent lethality seen with RNAi of mrp-5. To further 
investigate the precise heme requirements of mrp-5(ok2067/ok2067) worms, homozygous 
mutants or their wildtype broodmate were grown in various levels of supplemented heme, 
and the viability of their offspring was scored by checking for embryonic lethality 
(Figure 3A). Embryonic lethality was observed at ≤ 80 µM supplemented heme, and total 
embryonic lethality was observed at ≤ 50 µM heme. It was also apparent that in addition 
to the viability defect of offspring, mrp-5 deficiency resulted in delayed development 
(Figure 3B). By 93 h, F1 embryos were already laid at ≥ 100 µM heme, while F1 embryos 
did not appear on plates supplemented with 40 µM heme until 117 h. At the final time 
point of 167 h, worms with no supplemented heme were still at the L4 stage. The 
wildtype broodmate showed F1 progeny hatching by 67 h regardless of heme 
supplementation (Figure 3B). Importantly, this assay also provided the growth conditions 
under which a forward genetic screen for suppression of lethality could be conducted. 
With heme supplementation ≤ 50 µM, mrp-5(ok2067/ok2067) worms will not lay viable 
progeny.  
A Forward Mutagenesis Screen for Suppression of mrp-5(ok2067) Lethality 
 EMS has been used extensively as a mutagen in forward screens in C. elegans82. 
It is an alkylating agent capable of inducing random single base pair transitions, as well 





induced mutations consist of simple guanine (G) to adenine (A) transitions.82 EMS 
mutagenesis was conducted on ~20,000 early L4 P0 mrp-5(ok2067/ok2067) worms, 
inducing germ line mutations (Figure 4). These germ line mutations were propagated 
though self-fertilization in the P0, and appeared somatically as heterozygous mutations in 
the ~80,000 F1, representing ~160,000 haploid genomes, or an eight-fold genomic 
coverage.82 Self-fertilization in the F1 and subsequent screening of the F2 on NGM plates 
supplemented with 30 µM heme yielded 32 suppressors which laid viable F3 progeny 
(Figure 4).  
 Given the relatively large number of suppressor lines isolated, a strategy was 
necessary to prioritize the mapping of suppressor mutants. Typically when a genetic 
screen reaches saturation, there is a potential for the generation of allelic suppressors. 
Independently mapping allelic suppressors would be a waste of resources, and testing for 
genetic complementation is a straightforward means of identifying allelic suppressors and 
prioritizing mapping to identify suppressor alleles in unique genes.82,84 This assumes 
suppression is recessive, and involves intercrossing of suppressor lines to check if 
heterozygous progeny for paternal/maternal suppressor alleles maintain or lose 
suppression; if suppression is maintained, one possible conclusion is that the two 
suppressor alleles are in the same gene. It quickly became clear that this approach would 
not be pragmatic in the case of analyzing these mutants, due to the fact that mrp-
5(ok2067/O) males are defective in mating (Figure 5). As hermaphrodites, mrp-
5(ok2067/ok2067) worms mate normally with wildtype males (Figure 5A-B), indicating 
the defect is paternal. Furthermore, there are no issues with self-fertilization indicating 





characterized mating behaviors85, there is a possibility that there is a defect in sperm 
motility or the male mating apparatus. Indeed, mrp-5(ok2067/O) males exhibit stunted 
fan formation, reduced number of rays, and potentially defective spicule retraction 
(Figure 5C). Interestingly, although suppressor mutants are capable of suppressing mrp-
5(ok2067) associated lethality, they are still deficient in mating and heme 
supplementation does not rescue the mating defect (Figure 5B). It is possible that mrp-5 
plays additional roles outside of its capacity in intestinal heme homeostasis and that 
genetic suppressors or heme supplementation do not overcome this function. It is also 
possible that the male tail defects are due to a background mutation which has remained 
linked to mrp-5(ok2067) though twelve backcrosses. Given that testing for genetic 
complementation among suppressors was not feasible, we adopted other means to 
prioritize mapping of suppressor mutants. 
 One obvious property to sort mrp-5 suppressor mutants was to gauge the strength 
of their ability to suppress mrp-5 growth deficiency (Figure 6). Worm viability in heme 
supplementation ranging from 0, 10, 20, and 30 µM was assayed over several generations 
(P0, F1, F2). Suppressor mutants were grouped by the lowest level of heme 
supplementation where hatching F2 progeny were observed three days after P0 removal. 
These parameters were chosen to given the highest level of stratification among the 
strongest suppressors. 
 Suppressor strains were named IQ1xxx. The first x indicates the lowest level of 
heme supplementation where viable F2 were observed (10 µM). The next two xx digits 
indicate an arbitrary designation within that group. IQ1001 is not necessarily a stronger 





would be preferable for initial mapping due to the fact that a strong suppression would be 
most evident in a mapping cross experiment. Subsequent analysis of suppressor strains 
prior to mapping was therefore generally restricted to stronger suppressors. 
 Since mrp-5 suppressor mutants exhibit the ability to grow in low heme 
conditions insufficient for mrp-5 mutant growth, we reasoned that this is due to a rescue 
of heme efflux from the intestine. Previous work demonstrated that loss of mrp-5 results 
in reduced toxicity when exposed to a toxic heme analog, gallium protoporphyrin IX 
(GaPPIX), indicating that MRP-5 is capable of effluxing GaPPIX and that retention of 
GaPPIX in the intestine attenuates its toxicity.40 Presumably, rescue of intestinal heme 
efflux would also result in a reversion to wildtype lethality upon GaPPIX exposure. A 
GaPPIX lethality growth curve was conducted to establish ideal conditions, and GaPPIX 
lethality in suppressor mutants was tested (Figure 7B). All mrp-5 suppressors tested 
showed a reversion of GaPPIX lethality to wildtype levels. Interestingly, stronger 
suppressors (IQ10xx) showed higher lethality than most intermediate suppressors with 
the exception of IQ1207 (IQ11xx, IQ12xx) indicating that mrp-5 suppression is due to a 
restored efflux of heme from the intestine and the degree to which heme efflux is rescued 
is also reflected in the toxicity of GaPPIX. It is possible that IQ1207 is a strong 
suppressor in terms of the rescue of porphyrin efflux, but that there are is another 
background mutation which is limiting its growth. The readout of these assays depend on 
whether intestinal porphyrin efflux is occurring by assaying phenotypes associated with 
delivery to extra-intestinal tissues, but make no differentiation in the mechanism of this 





intestinal porphyrin efflux would be more likely to highlight distinct mechanisms of 
suppression in these mutants. 
 One such assay is metabolic labeling with the fluorescent heme analog, zinc 
mesoporphyrin (ZnMP). ZnMP treatment has been used in C. elegans and other systems 
as a proxy to visualize heme trafficking.26,34,40,86,87 C. elegans accumulates ZnMP in 
intracellular punctae within the intestine. Loss of hrg-1 or mrp-5 increases the intensity of 
accumulation at these sites, while loss of hrg-4 results in a loss of ZnMP signal.34,40 
ZnMP treatment was carried out in mrp-5(ok2067/ok2067), mrp-5(+/+), and mrp-5 
suppressor mutant worms (Figure 8). As previously reported40, mrp-5(ok2067/ok2067) 
worms show an increase in accumulation of ZnMP as compared to mrp-5(+/+) worms. 
Interestingly, of the five suppressors tested, there were two general phenotypes observed. 
IQ1003, IQ1004, and IQ1005 all showed a total loss of any ZnMP signal. In contrast, 
IQ1001 and IQ1002 both retained high levels of ZnMP accumulation (Figure 8). This 
result suggests that while all strains tested rescue heme efflux sufficiently to grow 
without heme supplementation, they appear to do so by at least two distinct mechanisms. 
In addition, it would be ideal to map suppressors of both phenotypes to maximize the 
likelihood of identifying non-allelic suppressors. 
Hawaiian Variant Mapping of mrp-5 Suppressor Mutants 
 With a small group of suppressors prioritized, the next step was to map suppressor 
mutations to a genetic locus. SNP-based deep sequencing offered a relatively high 
throughput means for identifying mutations in strains isolated from a forward genetic 
screen, and is widely used and well established in C. elegans82. The Hawaiian strain 





level of sequence divergence among C. elegans wild isolates88 (Figure 9). There is an 
average of one SNP per 1kb between the N2 and Hawaiian strains.82,89  
 First, the mrp-5(ok2067) allele was introgressed from the N2 strain to the 
Hawaiian background though nine backcrosses, yielding a Hw; mrp-5(ok2067/ok2067) 
mapping strain. The mapping cross required crossing of this mapping strain and a 
suppressor mutant; however, this task was complicated by the fact that as previously 
stated, mrp-5(ok2067/O) males mate with a very low frequency. To circumvent this issue, 
all F1 progeny of the mapping cross were clonally picked and subsequently genotyped for 
Hw/N2 SNPs. Only bona fide F1 cross progeny which were heterozygous for Hw/N2 
SNPs were used (Figure 10). We chose to map IQ1003, IQ1004, and IQ1005 due to the 
fact that they’re all strong suppressors, and share a similar ZnMP phenotype (Figure 8).  
 We picked ~300 F2 recombinant lines clonally to plates without added heme. F2 
worms were allowed to self-fertilize, and plates were screened for hatching of the F3 
generation. Under these low heme conditions, only worms capable of suppressing mrp-5 
lethality would lay viable F3 animals. Each of the three suppressor mutants exhibited 
slightly less than 25% suppression of mrp-5 embryonic lethality among recombinant F2 
lines as expected of a recessive suppressor. One possible explanation for this is that there 
are known incompatibilities between Hawaiian and N2 alleles. A well studied example is 
the zeel-1, peel-1 interaction on the left arm of chomosome I where embryos homozygous 
for a naturally occurring deletion in zeel-1 arrest if the paternal contribution contains a 
Hawaiian variant in peel-1. This is an unintentional selection and results in a bias towards 





suppressor mutants are in fact multigenic rather than containing only a single suppressor 
allele. 
 At least 49 recombinant F2 lines were pooled; greater than 50 recombinant F2 
lines have a minimal contribution in increasing the resolution of the mapping interval.82,90 
Pooled recombinant F2 lines were sequenced along with the paternal mapping strain (Hw; 
mrp-5(ok2067/ok2067)) and the original pre-mutagenesis strain (N2; mrp-
5(ok2067/ok2067)). The online mutant analysis pipeline CloudMap80 was used to analyze 
NGS data and construct mapping plots (Figure 11).  
 Identification of a region containing the putative suppressor allele, or mapping 
interval, requires the observation of a region of unexpected N2 linkage. Since the 
suppressor allele is linked to the N2 background, and only worms homozygous for this 
allele should survive screening, the suppressor allele region should show complete N2 
linkage. In all mrp-5 suppressor mutant sequences analyzed, there was a strong region of 
N2 linkage on the right arm of the X Chomosome at the mrp-5 locus (~15Mb), fitting 
with, the fact that the mrp-5 allele in this region was introgressed from the N2 
background (Figure 11A-C). A putative mapping interval should be a region of complete 
N2 linkage of roughly two Mb (due to the number of recombinant lines sequenced).82,89,90 
All mutants also showed a slight N2 linkage on the left arm of Chomosome I around 
2.5Mb (Figure 11A-C), which corresponds to the previously described zeel-1, peel-1 
locus.88 These regions were expected sites of N2 linkage and were initially not considered 
as regions containing suppressor alleles.  
 IQ1003 did not have any other regions of N2 linkage. In addition, the left arm of 





linkage was around 1Mb rather than 2.5Mb near the zeel-1, peel-1 locus (Figure 11A). 
For these reasons the mapping interval for the mrp-5 suppressor allele ih1003 was chosen 
as the first 2Mb on the left arm of chomosome I (Figure 11D).  
 IQ1004 showed a region of strong N2 linkage centered at 4Mb on chomosome II 
(Figure 11B). The mapping interval for the mrp-5 suppressor allele ih1004 was chosen as 
3-5Mb on chomosome II (Figure 11D). 
 IQ1005 showed no strong linkages to N2 anywhere except the X chomosome 
(Figure 11C). In addition to the mrp-5 locus ~15Mb, there was a region of strong N2 
linkage on the left arm of the X chomosome centered around 1Mb; neither of the other 
two mutants analyzed showed any linkage on the X chomosome besides the mrp-5 locus. 
Thus the mapping interval for the mrp-5 suppressor allele ih1005 was chosen as the first 
2Mb of the X chomosome (Figure 11D).  
 The next step was to construct a list of candidate suppressor alleles in each of 
these regions (Figure 11E). The snpEff function in the workflow used for mutant 
sequence analysis80 predicts the effect of a SNP at the protein level. Effects most likely to 
disrupt normal protein function were prioritized as candidates, including mutations 
categorized as missense, nonsense, frameshift, or those likely to have an effect on mRNA 
splicing. IQ1004 had six candidate alleles, IQ1005 had four candidate alleles, and 
IQ1003 only had a single candidate allele in their respective mapping intervals. 
Interestingly, all three suppressor mutant candidate alleles included a unique subunit of 
adaptor protein complex 3 (AP-3), indicating a strong likelihood that all three suppressor 





 The most straightforward means to identify which mutant allele is responsible for 
suppression of mrp-5 was to conduct RNAi knockdown against each candidate in the 
original pre-mutagenesis strain, mrp-5(ok2067/ok2067), under low heme conditions. 
Assuming that the suppressor allele is a loss of function mutation, RNAi knockdown of 
the true suppressor allele will recapitulate the suppression of mrp-5 lethality in low heme, 
but no other candidate gene RNAi will have an effect. Although unlikely, it is possible 
that a gain of function mutation could be recessive. If this were the case, RNAi 
knockdown of the true suppressor allele in the suppressor strain would result in a loss of 
mrp-5 suppression, but not in any other candidate. The former strategy was adopted first 
because it is more likely that a recessive suppressor allele is a loss of function. RNAi 
knockdown of the suppressor alleles in mrp-5(ok2067/ok2067) worms over two 
generations resulted in a suppression of mrp-5 lethality for subunits of all four subunits of 
AP-3, but not in any other candidate gene (Figure 12). Although only three subunits of 
AP-3 (apd-3, apm-3, aps-3) were candidates, the fourth (apb-3) was included. The details 
of the molecular lesions in suppressor alleles apd-3(ih1004), apm-3(ih1005), and aps-
3(ih1003) are described (Figure 13A-C). Mutants have previously been generated and are 
available from the CGC for apd-3, apb-3, and apm-3; however, this is the first reported 
mutant allele of aps-3. Likely, this is because its small genomic locus (619bp) makes it 
an unlikely target of random mutagenesis (Figure 13A). 
AP-3 suppression of general mrp-5 deficiency 
 The candidate verification in mrp-5(ok2067/ok2067) worms showed that RNAi 
induced deficiency of genes encoding AP-3 subunits was capable of suppressing lethality 





alleles. To see if this is true of general mrp-5 deficiency or if these suppressors were 
informational suppressor alleles, combinatorial RNAi of candidate suppressor genes was 
conducted with or without mrp-5 (Figure 14). Subunits of AP-3, but no other candidates, 
resulted in a significant suppression of mrp-5 RNAi induced loss of viability (Figure 
14A). Additionally, RNAi knockdown of candidate genes in combination with vector had 
no impact on viability (Figure 14B) indicating that AP-3 subunit mutant alleles identified 
in our screen were directly responsible for the mrp-5 suppression. It also indicates that 
neither AP-3 subunits nor mrp-5 are allele specific in this regard. Mutant alleles or RNAi 
of AP-3 are capable of suppressing lethality caused by mrp-5 deficiency implying that 
AP-3 subunit mutants are bypass suppressors of mrp-5 deficiency.  
Testing of other Adaptor Protein Complexes 
 To test whether adaptor protein deficiency suppressing mrp-5 deficiency was 
unique to AP-3 or if this was a general feature of adaptins, RNAi of genes encoding AP-2 
and AP-1 subunits was conducted in mrp-5(ok2067/ok2067) worms (Figure 15). RNAi 
knockdown of genes encoding AP-2 subunits resulted in suppression of mrp-5 loss of 
viability. However, RNAi knockdown of genes encoding AP-1 subunits had no effect on 
the mrp-5 phenotype. To test this in a second system of mrp-5 deficiency as well as to 
ascertain the impact of knockdown of these subunits alone, combinatorial RNAi was 
conducted against genes encoding AP-1 and AP-2 subunits with or without RNAi against 
mrp-5 (Figure 16). In concordance with the mrp-5(ok2067) result, RNAi against genes 
encoding AP-2 subunits but not AP-1 subunits suppressed mrp-5 RNAi lethality (Figure 
16A). However, combination with vector RNAi demonstrated that knockdown of genes 





resulted only in mild brood size reduction (Figure 16B). These experiments demonstrate 
that although only genes encoding subunits of AP-3 were identified in the suppressor 
screen, RNAi knockdown of genes encoding AP-2 subunits also results in a suppression 
of mrp-5 lethality. However these experiments do not sufficiently address whether AP-1 
may have the same capacity due to the fact that RNAi of a gene encoding an AP-1 
subunit is lethal. This question could potentially be probed in the future by starting AP-1 
knockdown later in development rather than from the L1 stage. 
Effect of AP-3 Subunit loss on Systemic Heme Status 
 The fact that loss of AP-3 seems to rescue worm viability as well as reversion to 
GaPPIX toxicity in the absence of mrp-5 indicates that loss of AP-3 subunits in an mrp-5 
deficient background results in a restoration of porphyrin efflux from the intestine. To 
test if heme levels in extra-intestinal tissues are truly restored, we looked for a rescue of 
tissue specific heme deficiency signals. First, the effect of combinatorial RNAi was 
examined in an hrg-1 transcriptional reporter strain, IQ6015 (Figure 17). Despite being 
transcribed in the intestine, hrg-1 promoter activity acts as a reporter of whole animal 
heme status, and is inversely correlated with heme levels.39,41 As expected, knockdown of 
mrp-5 results in an increase in GFP signal.40 Knockdown of genes encoding AP-3 
subunits does not have a significant impact on hrg-1 transcription alone (with vector). 
Additionally, no subunit is able to significantly suppress the increased signal due to mrp-
5 RNAi, although aps-3 RNAi resulted in a consistent mild attenuation of hrg-1 promoter 
activity, which was statistically insignificant.  
 To examine the effect of AP-3 subunit deficiency on an extra-intestinal reporter, 





driven by the hrg-2 promoter, IQ8125 (Figure 18). The hrg-2 promoter is active in the 
hypodermis, and is negatively regulated by heme.40,76 A caveat here is that since  this is a 
fusion protein it is not equitable to the transcriptional reporter if there are any post-
translational effects. As expected, mrp-5 RNAi caused in increase in HRG-2-YFP signal, 
indicating hypodermal heme deficiency. Dietary supplementation of heme but not 
knockdown of AP-3 subunits suppressed this hypodermal heme deficiency signal. These 
experiments indicate that while AP-3 subunit mutants are capable of suppressing 
macroscopic mrp-5 phenotypes such as lethality, they do not show suppression of heme 
responsive reporters. Given that mrp-5 RNAi growth defects were rescued by 
supplementing  ≥50 µM heme but Phrg-1::gfp remained active with ≥500 µM heme  
supplemented, this result is not unsurprising.40 
 To get a more complete picture of tissue heme status independent of signaling, a 
similar experiment was conducted on genetically encoded tissue specific HRP reporters. 
HRP requires heme as a cofactor for activity and HRP activity is a measure of heme 
availability in the secretory pathway.77 IQ6351 contains an ER targeted HRP driven from 
the constitutive, intestine-specific promoter of vha-691, and IQ6352 contains the same 
transgene but driven from the hypodermis-specific promoter of dpy-777,92. Combinatorial 
RNAi against genes encoding AP-3 subunits and mrp-5 or genes encoding AP-3 subunits 
alone (+vector) was carried out in these strains (Figure 19). In the intestine, HRP activity 
was increased with the knockdown of mrp-5, consistent with previous results.77 There 
was a mild increase in HRP activity in the knockdown of some AP-3 subunit genes, and 
interestingly, all AP-3 subunit genes except aps-3 showed an additive increase in activity 





reporter, knockdown of mrp-5 resulted in lower heme loading of HRP which is consistent 
with previous results.77 As in the intestine, knockdown of AP-3 subunits resulted in a 
similar increase in HRP activity. In combination with mrp-5 RNAi, knockdown of AP-3 
subunits increased HRP activity compared to knockdown of mrp-5 alone (Figure 19B). 
This indicates that in fact, AP-3 subunit deficiency does suppress the decrease in activity 
due to mrp-5 deficiency. Notably the suppression is relatively mild and remains 
significantly lower than vector only conditions. This result could be the potential 
explanation for the lack of suppression of mrp-5 heme deficiency signals as heme levels 
in peripheral tissues are restored to a sufficient degree to rescue viability but insufficient 
to suppress heme responsive reporters. Since the HRP readout is dependent on heme 
availability to an ER reporter, it is likely dependent on heme availability in the secretory 
system and may not be representative of total tissue heme status. AP-3 subunits are 
expressed ubiquitously93, and RNAi knockdown of AP-3 subunit genes is systemic; thus, 
changes in heme availability in the hypodermis could be the result of mistrafficking of 
hypodermal heme stores to a secretory compartment rather than a reflection of a change 
in total hypodermal heme levels due to an increase in intestinal efflux. This could be 
addressed by tissue specific RNAi of AP-3 subunits in the intestine. These data indicate 
that loss of AP-3 causes an increase in heme efflux from the intestine which could be due 
to an increase in heme efflux specifically, or perhaps efflux of all materials is increased 
non-specifically.  
 To determine the specificity of AP-3 complexes on micronutrient trafficking, we 
analyzed cua-1 mutants. Preliminary work in the Kim lab has demonstrated the copper 





an intestinal copper exporter and loss of cua-1 is lethal.94,95 These parallels to heme 
trafficking and the ease of scoring suppression of a lethal phenotype made copper 
homeostasis an attractive system to gauge the universality of AP-3 mutant suppression of 
micronutrient export deficiency. RNAi against cua-1 was conducted in N2 or apb-3 
mutants and the effect on viability was tested in normal and high copper as well as copper 
limiting conditions in the presence of BCS, a copper chelator (Figure 20). Vector RNAi 
conditions suggest that in ideal copper conditions, N2 and apb-3 mutants show identical 
growth. However, apb-3 mutants are less viable than N2 in extreme copper conditions. 
RNAi knockdown of cua-1 resulted in decreased viability compared to vector, except 
with supplementation of copper. Interestingly, cua-1 knockdown in apb-3 mutants 
resulted in a complete loss of viability in any copper growth conditions (Figure 20). The 
primary interpretation from this result is that unlike in heme homeostasis, apb-3 
deficiency does not suppress loss of viability due to deficiency in intestinal export, but 
instead sensitizes them. Overall, these results suggest that AP-3 deficiency does not 
suppress deficiency in intestinal export for all micronutrients.  
Gut Granules 
 The majority of work regarding AP-3 function C. elegans deals with its role in the 
biogenesis of gut granules, an intestine specific lysosome related organelle (LRO). AP-3 
subunit mutants do not develop gut granules, an obvious phenotype due to the fact that 
gut granules are autofluorescent72,96 and a prominent feature of the worm intestine. Given 
that the AP-3 mutant mrp-5 suppressors isolated from the screen showed a complete loss 
of ZnMP accumulation (Figure 8), we examined whether the lack of ZnMP vesicles and 





problematic due to the poor mating of mrp-5(ok2067/O) males, we sought to reconstruct 
an AP-3 mutant mrp-5 suppressor. An independently generated AP-3 subunit mutant 
strain RB662 (apb-3(ok429/ok429)) which was isolated in a screen for loss of gut granule 
(glo) mutants70 was crossed to mrp-5(ok2067/ok2067) worms to yield IQ1901, as well as 
wildtype broodmates (1. mrp-5(+/+); apb-3(+/+), 2. mrp-5(+/+); apb-3(ok429/ok429)).  
 To ascertain if there is a relationship between ZnMP vesicles and gut granules we 
exposed each of these strains with ZnMP and analyzed them by confocal microscopy 
(Figure 21). In wildtype worms, there is in fact an overlapping population of gut granules 
and ZnMP containing vesicles, and in apb-3(ok429/ok429) mutants there is no detectable 
signal for gut granules or ZnMP, irrespective of the mrp-5 genotype. It has been reported 
that gut granules represent a terminal endocytic compartment, and that anything taken up 
though fluid phase endocytosis, such as TRITC-BSA, will localize to these 
compartments.70,97 However, loss of the heme importer hrg-4 prevents ZnMP 
accumulation in the intestine, indicating that localization to these sites does not depend 
on a non-specific endocytic pathway.34 Interestingly, although the apb-3(ok429/ok429) 
mutants have no gut granules, there appears to be autofluorescent material accumulated 
in the intestinal lumen (Figure 21). This phenotype was originally observed in a genetic 
screen for glo mutants, and the authors hypothesized that as a result of defective gut 
granule biogenesis, material normally trafficked to these organelles mistraffick to the 
plasma membrane, releasing their contents into the lumen (apical) or pseudocoelom 
(basolateral).70,97 Given that ZnMP accumulates in these vesicles, this possible 






 Intrigued by the role gut granules may be playing in intestinal handling of 
porphyrins, we sought to explore this relationship further. Is the suppression of mrp-5 due 
to the loss of gut granules, or some upstream trafficking event mediated by AP-3? If the 
mrp-5 suppression phenomenon is a direct result of gut granule loss (glo), then mutations 
in other glo genes would also result in a similar phenotype. We therefore tested the 
viability of pgp-2, glo-1, and glo-2 mutants when exposed to mrp-5 RNAi (Figure 22). 
While glo-1 and pgp-2 localize to gut granules and are required for their normal 
biogenesis, glo-2 is a BLOC-1 complex subunit, which in mammalian cell lines has been 
shown to interact with AP-3 and be required for normal trafficking of AP-3 cargo98-100. 
However, C. elegans BLOC-1 seems to have functions in trafficking to gut granules 
independent of AP-3.71 As expected, mutations in AP-3 subunits apd-3 and apb-3 
suppress mrp-5 lethality without the addition of heme, while other glo mutants tested did 
not suppress mrp-5 depletion. AP-3 subunit mutants do not show complete suppression; 
mrp-5 RNAi results in a smaller population than vector treatment. Most interestingly, 
supplementation of heme does not improve the viability of AP-3 mutants like it does for 
N2 or other glo mutants (Figure 22).  
Role of Other Heme Homeostatic Components in AP-3 Deficiency 
 Given that several components mediating intestinal heme trafficking have 
previously been identified34,40,41,43, we determined the role of these when AP-3 is 
depleted. Given that ZnMP accumulates in gut granules and HRG-1 has been shown to 
co-localize with ZnMP vesicles36, we examined whether loss of AP-3 may affect HRG-1 
localization. IQ6112 worms, which express HRG-1-MCHERRY fusion protein, were 





localization was examined by confocal microscope (Figure 23). In wildtype worms, 
HRG-1-MCHERRY localizes to small vesicles near the apical surface, consistent with 
previous reports.36 However, HRG-1-MCHERRY was not co-localized to autofluorescent 
vesicles, indicating that ZnMP accumulates in HRG-1 vesicles as well as gut granules 
and that these represent two distinct sites of ZnMP accumulation. Loss of AP-3 subunits 
resulted in a slight perturbation of apical concentration of HRG-1-MCHERRY vesicles. 
However, knockdown of genes encoding AP-2 subunits resulted in a more pronounced 
mis-localization of HRG-1-MCHERRY to enlarged punctae which were distinct from 
sites of auto-fluorescence. This result is consistent with our in silico observation that 
HRG-1 harbors canonical C-terminal sorting signals recognized by adaptins. However, 
the fact that mis-localization was more dramatic with loss of AP-2 implies that HRG-1 
trafficking may be mediated by AP-2, which is generally responsible for trafficking of 
components from the plasma membrane to recycling endosomes, and suggests that HRG-
1 may be recycling between the plasma membrane and an endocytic compartment.51 
Interestingly, studies in other model organisms have indicated that in polarized cells, AP-
2 mediates recycling from the basolateral plasma membrane51, which contradicts the 
generally conserved apical association of HRG-1 proteins.34-36 This could represent a 
functional divergence in C. elegans regarding a role of adaptins in mediating apical 
sorting, as indicated by the requirement of AP-1 for the normal apical sorting of PAR-
6.101 
 Given that loss of adaptors appears to alter the function of heme homeostatic 
components, we determined if any known components are uniquely important in 





hrg-3, and hrg-7 was conducted in the apb-3;mrp-5 mutant strain IQ1901 and its three 
wildtype broodmates, and viability was assayed (Figure 24). As expected, loss of any 
component except mrp-5 did not impact viability in wildtype worms (Figure 
24A).36,40,41,43 Interestingly, apb-3 mutants showed a general loss of viability when 
supplemented with high heme, indicating loss of AP-3 subunits results in susceptibility to 
heme toxicity (Figure 24B). This raises the possibility that loss of apb-3 results in 
increased heme efflux, and that this efflux is unregulated, such that in high environmental 
heme apb-3 mutants are incapable of attenuating efflux resulting in toxicity.  
 In mrp-5 mutant worms (Figure 24C), viability is restored with supplementation 
of dietary heme. Unexpectedly, loss of hrg-4 in mrp-5 mutants causes a complete loss of 
viability which cannot be rescued by heme supplementation. The synthetic lethality 
between hrg-4 and mrp-5 which cannot be rescued by heme is the first report of a lethal 
hrg-4 phenotype36, and suggests a clear distinction between heme imported by HRG-1 
and HRG-4. This is also unexpected due to the high level of redundancy of intestinal 
heme import in C. elegans. It appears that hrg-1and its paralogs hrg-5 and hrg-6 are not 
sufficient to act as heme importers in the absence of hrg-4 if mrp-5 is lost. A potential 
complication arises from the high homology between hrg-1, hrg-4, hrg-5, and hrg-6. If 
RNAi transitivity against hrg-4 resulted in generation of secondary siRNA102 
complementary to other hrg paralogs, it could result in an unintended knockdown of 
other hrg-1 paralogs. In fact, previous work has indicated that hrg-4 RNAi results in a 
decrease in hrg-6 promoter activity35. To differentiate between this being an hrg-4 
deficiency phenomenon and not an artifact of RNAi, mrp-5 RNAi could be conducted in 





transitivity does not play a role in the off target knockdown of hrg-4 by hrg-1 RNAi 
treatment. 
 Surprisingly, mrp-5; apb-3 double mutants (Figure 24D) showed a loss of 
viability with RNAi knockdown of hrg-4, hrg-3, and hrg-7 in low heme. A possible 
explanation is that hrg-3 and hrg-7 have been reported to effect viability in low heme 
conditions.41,43 Thus lethality without heme supplementation could simply be due to the 
fact that simultaneous deficiency of AP-3 subunits and mrp-5 results in relatively heme 
starved worms based on analysis of systemic heme status. Nonetheless, heme does not 



















Figure 1: mrp-5 RNAi embryonic lethality is increased later in a brood 
(A) A protocol schematic for Figure 1B.  (B) Approximately 10 synchronized L1 N2 
worms (P0) obtained from bleaching were placed onto 35 mm plates pre-seeded with 
HT115(DE3) bacteria expressed dsRNA against knockdown vector control or mrp-5. P0 
worms were moved to a fresh plate of the same conditions every 24 h following the 













Figure 2: Genomic structure of mrp-5(ok2067) and putative protein topology 
Picture of genetic locus was adapted from material obtained from www.wormbase.org; 
membrane protein topologies were generated using TMHMM 2.0103 and drawn using 







































Figure 3: mrp-5(ok2067/ok2067) heme growth curve 
(A) NGM agar plates were seeded with OP50 grown overnight in LB supplemented with 
the indicated concentration of hemin. Worms were maintained for one generation on 200 
µM heme NGM plates, and their progeny were synchronized. Approximately 50 
synchronized L1 (P0) were seeded onto each plate and observed daily. Once F1 embryos 
were observed on a plate, P0 were removed and hatching was scored 24 h later. No 
embryos were observed at 10 or 20 µM heme. (B) During the course of the experiment 
described in Figure 3A, the P0 generation duration was scored by duration between 


















Figure 4: EMS screen schematic 
N2; mrp-5(ok2067ok2067) worms were maintained in axenic mCeHR-2 media 
supplemented with 200 µM hemin. Following EMS treatment (see methods), 
mutagenized P0 animals were moved back to axenic mCeHR-2 media supplemented with 
200 µM hemin and allowed to lay F1 progeny. Gravid F1 were bleached to isolate and 
synchronize the F2 generation, which were then placed on 38 10 cm plates supplemented 
with 30 µM heme. Viable F3 were picked to fresh NGM plates seeded with 30 µM heme 































Figure 5: Mating deficiency in mrp-5(ok2067/o) males 
(A) Mating plates consisted of 35mm NGM plates with a 10 µL spot of 200 µM hemin 
OP50 culture. Seven males of the indicated strain were picked onto a plate with one 
sperm exhausted N2 hermaphrodite. Presence of progeny was used as a measure of 
mating success due to the fact that hermaphrodites were sperm exhausted. (B) Mating 
plates consisted of 35 mm NGM plates where 200 µM hemin chloride was supplemented 
directly to the NGM, and were seeded with a 10 µL spot of 200 µM hemin OP50 culture. 
Six males of the indicated strain were picked onto a plate with one virgin unc-119 
hermaphrodite, which have a high mating success due to their relative lack of 
locomotion. Once progeny were observed, all parents were removed from the plate by 
aspiration. Mating success was scored by checking if progeny contained males. (C) Males 
of both strains were grown for at least one generation on NGM agar plates directly 
supplemented with 100 µM hemin. Males were placed onto agar pads with M9 and 1mM 
NaN3. Images were taken using a DMIRE2 epifluorescence microscope (Leica) 














Male Strain # with Progeny # with No Progeny Total 
mrp-5(ok2067/o) 0 7 7 
IQ1001 1 16 17 




Male Strain # successful # unsuccessful Total 
mrp-5(ok2067/o) 1 (<10% progeny) 18 19 











Figure 6: Suppression strength assay 
(A) P0 worms were grown on plates seeded with 100 µM hemin OP50. Three P0 animals 
were moved as L4 larvae to plates supplemented with 0 µM, 10 µM, 20 µM, or 30 µM 
hemin. Once F1 progeny were laid, P0 worms were removed. Three days following 
removal of the P0, the growth of the F1 and hatching of F2 was scored. Suppressor strains 
were categorized by the lowest concentration of heme supplementation where hatching F2 
progeny were observed three days following P0 removal. (B) Representative photographs 




































Figure 7: GaPPIX lethality in mrp-5 suppressor mutants 
 (A) Gallium Protoporphyrin IX (GaPPIX) was directly supplemented to 35mm NGM 
agar plates, which were then seeded with 200 µL OP50. Approximately 50 synchronized 
L1 worms were placed on plates at time 0, and lethality was scored at the indicated time 
points. Lethality was determined by a complete lack of movement and failure of a worm 
to respond to tactile stimulus. (B) Plates were prepared as described. All strains were 
maintained for one generation on NGM plates supplemented with 100 µM heme, and 





























Figure 8: ZnMP uptake in mrp-5 suppressor mutants 
The indicated strains were grown and treated with ZnMP as described. WT refers to the 
mrp-5(+/+) broodmate of mrp-5(ok2067/ok2067), while mrp-5 refers to mrp-
5(ok2067/ok2067). Images were taken using a DMIRE2 epifluorescence microscope 
(Leica) connected to a Retiga 1300 cooled mono 12-bit camera, and ZnMP signal was 
detected by rhodamine filter. Exposure time was calibrated with worms not exposed to 

























Figure 9: Hawaiian Variant Mapping Strategy 
A general scheme for the Hawaiian Variant Mapping approach assuming the simplest 
case of a recessive suppressor. Paternal mapping strain (Hw; mrp-5(ok2067/O)) is 
crossed to a hermaphrodite suppressor mutant. F2 progeny are picked clonally to low 
heme. Only F2 recombinant lines homozygous for the suppressor allele will lay viable F3. 
Pooling of recombinant F2 lines and subsequent sequencing should reveal no bias towards 





























Figure 10: Hawaiian Variant Mapping – F1, F3 screening 
(A) A schematic of the strategy for ensuring F1 are the product of the indicated cross 
rather than self-progeny of the hermaphrodite. Genotyping for the background strain 
using snip-SNPs was conducted as described. (B) A report of screening of the F1 
screening containing the observed ratio of males and bona fide cross progeny confirmed 
by heterozygosity for Hawaiian and N2 SNPs. (C) A report of the ratio of suppression of 






























Figure 11: Hawaiian variant mapping results – IQ1003, IQ1004, IQ1005 
(A-D) All mapping plots were generated using “CloudMap Hawaiian Variant Mapping 
with WGS and Variant Calling workflow” published by gm212380 on the Galaxy web 
server. For a given chomosome (linkage group, LG), the top plot represents the ratio of 
Hawaiian to N2 versions of a SNP, where each black dot represents an individual SNP. 
The red line represents an LOESS regression line of the frequency of Hawaiian SNPS as 
a function of genetic locus. The bottom plot represents the frequency of pure N2 alleles 
over a given interval. Red bars represent bin size of 0.5Mb and grey bars represent bin 
size of 1Mb. The mappings plots for (A) IQ1003, (B) IQ1004, and (C) IQ1005 are 
shown. (D) The mapping intervals for each strain are summarized. (E) Candidate genes 
generated by compiling all genes containing missence, nonsense, frameshift, or splicing 
variants (predicted by snpEff function of “CloudMap Hawaiian Variant Mapping with 
WGS and Variant Calling workflow” published by gm212380) within the indicated 
















































Figure 12: Candidate testing by RNAi in mrp-5(ok2067/ok2067) 
RNAi against candidate genes was conducted for a generation on 200 µM heme NGM 
plates, and these adults were moved clonally to the same RNAi conditions without heme 
supplementation, allowed to lay progeny overnight, then removed. The positive control 
condition was observed until the second generation reached adulthood, and then the 
entire population for all treatments was analyzed by COPAS BioSort (Union Biometrica). 
Data represents averages of three technical replicates from two independent experiments, 
where all populations were normalized as a percentage of the vector +200 µM Heme 
condition. Indicated significant differences compared to the vector treatment were 
obtained by post-hoc multiple means comparisons utilizing Bonferroni correction *** p < 





























Figure 13: AP-3 subunit suppressor alleles 
(A) The aps(ih1003) allele contains a substitution at nucleotide position 383 from a C to 
a T. This is predicted to result in a nonsense mutation of codon 115 from R to a stop, and 
result in a C-terminal truncation of 79 amino acids. (B) The apm-3(ih1005) allele 
contains a substitution at nucleotide position 1967 from a G to an A. The mutated 
guanine is predicted to act as a 5’ nucleophilic splice donor for the excision of intron 9. 
An effect on transcript splicing has not been confirmed. (C) The apd-3(ih1004) allele 
contains a substitution at nucleotide position 7,853 from a C to a T. This is predicted to 
result in a nonsense mutation of codon 761 from a Q to a stop, and result in a C-terminal 
truncation of 492 amino acids. (D) The genomic sequence of aps(ih1003) is reported. (E) 
The genomic sequence of apm-3(ih1005) is reported. (F)The genomic sequence of apd-
3(ih1004) is reported. Nucleotide positions refer to genomic sequence. Position 1 is the 
translational start site (A in ATG start codon). Genomic sequences contain the indicated 
mutation in red as well as up to 500bp of flanking sequence. Images of genomic loci are 
























































































Figure 14: Candidate testing by combinatorial RNAi 
The IQ6015 RNAi hypersensitive strain was synchronized and three L1s (P0) were placed 
onto NGM plates for combinatorial RNAi against he indicated gene(s); either mrp-5 and 
a candidate gene (A), or vector control and a candidate gene (B). Once the F1 generation 
reached gravid in the positive control treatment, total populations for each condition were 
analyzed by COPAS BioSort (Union Biometrica). Data represents the averages of three 
technical replicates from two independent experiments, where all populations were 
normalized as a percentage of the positive control treatment. Indicated significant 
differences compared to the vector treatment were obtained by post-hoc multiple means 




























Figure 15: RNAi against AP-1 or AP-2 subunit genes in mrp-5(ok2067/ok2067) 
RNAi against genes encoding subunits of adaptor protein complexes was conducted for a 
generation on 200 µM heme NGM plates, and these adults were moved clonally to the 
same RNAi conditions without heme supplementation, allowed to lay progeny overnight, 
then removed. The vector +200 µM heme positive control condition was observed until 
the second generation reached adulthood, and then the entire population for all treatments 
was analyzed by COPAS BioSort (Union Biometrica). Data represents averages of three 
technical replicates from two independent experiments, where all populations were 
normalized as a percentage of the vector +200 µM Heme condition. Indicated significant 
differences compared to the vector treatment were obtained by post-hoc multiple means 





















Figure 16: Combinatorial RNAi against AP-1 or AP-2 and vector or mrp-5 
The IQ6015 RNAi hypersensitive strain was synchronized and three L1s (P0) were placed 
onto NGM plates for combinatorial RNAi against he indicated gene(s); either mrp-5 and 
a gene encoding an AP subunit (A), or vector control and a gene encoding an AP subunit 
(B). Once the F1 generation reached gravid in the positive control treatment, total 
populations for each condition were analyzed by COPAS BioSort (Union Biometrica). 
Data represents the averages of three technical replicates from two independent 
experiments, where all populations were normalized as a percentage of the positive 
control treatment. Indicated significant differences compared to the vector treatment were 
obtained by post-hoc multiple means comparisons utilizing Bonferroni correction *** p < 
























Figure 17: AP-3 subunit RNAi in Phrg-1::GFP::unc-54 UTR; lin-15B(n744/n744) 
IQ6015 (Phrg-1::GFP::unc-54 UTR; lin-15B(n744/n744)) worms were synchronized, and 
40 L1s were placed onto NGM plates seeded with HT115(DE3) bacteria for 
combinatorial RNAi against either vector and genes encoding AP-3 subunits, or mrp-5 
and genes encoding AP-3 subunits. Integral GFP signal was obtained by analysis with 
COPAS BioSort (Union Biometrica) using a ~13mW 488nm laser for excitation, and a 
510(+/- 23)nm filter to detect emission. Integral GFP signal of each worm was 
normalized to the worm’s size (TOF), and the average of all adults in that technical 
replicate were averaged, then normalized to vector treatment. Data represents the 
averages from three independent experiments, where each experimental average is the 
mean of three technical replicates. Indicated significant differences are as compared to 
the vector + vector treatment unless indicated by a grey line, and were obtained by post-
hoc multiple means comparisons utilizing Bonferroni correction *** p < 0.001, ** p < 




























Figure 18: AP-3 subunit RNAi in Phrg-2::HRG-2-YFP::unc-54 UTR 
IQ8125 (Phrg-2::HRG-2-YFP; lin-15B(n744/n744)) worms were synchronized, and 40 L1s 
were placed onto NGM plates seeded with HT115(DE3) bacteria for combinatorial RNAi 
against either vector and genes encoding AP-3 subunits, or mrp-5 and genes encoding 
AP-3 subunits. Integral GFP signal was obtained by analysis with COPAS BioSort 
(Union Biometrica) using a ~13mW 488nm laser for excitation, and a 543(+/- 22)nm 
filter to detect emission. Integral GFP signal of each worm was normalized to the worm’s 
size (TOF), and the average of all adults in that technical replicate were averaged, then 
normalized to vector treatment. Data represents the averages of three technical replicates 
from two independent experiments. Indicated significant differences are as compared to 
the vector + vector treatment unless indicated by a grey line, and were obtained by post-
hoc multiple means comparisons utilizing Bonferroni correction *** p < 0.001, ** p < 


























Figure 19: HRP activity Assay in RNAi model of mrp-5 suppression 
Worms were bleached from stock plates (NGM, OP50) and ~10,000 synchronized L1s 
were plated to 10 cM plates seeded with 1.5mL of HT115(DE3) for combinatorial RNAi 
against the indicated genes. Worms were allowed to grow until at the young adult stage, 
washed twice with M9 and lysed in 100 µL buffer (150 mM NaCl, 20 mM HEPES, 0.5% 
Triton X-100, with Protease Inhibitor Cocktail Set III) and Lysing Matrix C beads (MP 
Biomedicals) in a FastPrep-24 Beadbeater (MP Biomedicals). Lysates were kept on ice at 
all times. A volume of (x) µL worm lysate (for IQ6311, x=2; for IQ6312, x=5) was 
mixed with (200-x) µL fresh peroxidase assay buffer (0.1 mg/mL o-dianasidine, 0.02% 
H2O2 in 0.1M NaH2PO4/Na2HPO4 buffer, pH 6) in 96-well plate; absorbance at 440nm 
(OD440) and 600nm (OD440) were immediately measured using a plate reader 
(SynergyHT, BioTek). Protocol adapted from described methods.77 Experiment was 
conducted with (A) IQ6351 (vha-6::ER-HRP-mcherry::unc-54 UTR; lin-
15b(n744/n744)) or (B) IQ6352 (dpy-7::ER-HRP-mcherry::unc-54 UTR; lin-
15b(n744/n744)) strains. Data represents the averages of three technical replicates. 
Indicated significant differences are as compared to the vector + vector treatment unless 
indicated by a grey line, and were obtained by post-hoc multiple means comparisons 






























Figure 20: cua-1(ok904) suppression assay 
Preceding the experiment, P0 worms of either N2 or apb-3(ok429/ok429) strain were 
synchronized as L1s and plated onto NGM plates seeded with HT115(DE3) for RNAi 
against either vector or cua-1. Once gravid, P0 worms were bleached, and F1 were 
synchronized as L1progeny. Three F1 L1s/well were placed onto NGM plates 
supplemented with BCS or CuCl2 and seeded with HT115(DE3) bacteria for RNAi 
against the indicated genes. The F1 of P0 grown on vector were used for vector or pop-1 
RNAi conditions, while the F1 of P0 grown on cua-1 were placed to cua-1 RNAi 
conditions. F1 worms were allowed to lay F2. Once F2 worms reached gravid for the 
vector, no supplementation treatment, all worms of that strain were analyzed by COPAS 






















Fig 21: ZnMP Treatment in suppressor mutants 
IQ1901(mrp-5(ok2067/ok2067);apb-3(ok429/ok429)), RB662(mrp-5(+/+);apb-
3(ok429/ok429)), and WT(mrp-5(+/+);apb-3(+/+)) worms were treated with ZnMP and 
imaged by confocal microscopy. ZnMP was excited by 561nm laser and emission was 
visualized by rhodamine filter. Autofluorescence was excited by 405nm laser and 































Figure 22: mrp-5 RNAi Suppression Assay 
N2, RB662(apb-3(ok429/ok429)), RB2257(apd-3(ok3058/ok3058)), JJ1271(glo-
1(zu391/zu391)), glo-2(zu445/zu445), GH378(pgp-2(kx48/kx48)) animals were 
maintained on NGM with no supplemented heme for one generation and then bleached. 
Three synchronized L1 (P0) progeny were placed on NGM seeded with HT115(DE3) for 
RNAi against the indicated gene. Once F1 treated with vector control reached gravid, all 
treatments for that strain were analyzed by COPAS Biosort (Union Biometrica). Data 





























Figure 23: AP-2 and AP-3 RNAi in Pvha-6::HRG-1-mCherry::unc-54 UTR 
RNAi against apb-3 is representative of apd-3, apm-3, aps-3 and RNAi against apa-2 is 
representative of apm-2, aps-2. Synchronized IQ6112 (Pvha-6::HRG-1-mcherry::unc-54 
UTR) L1s were plated onto NGM plates seeded with HT115(DE3) for RNAi against the 
indicated gene and allowed to grow for until at the young adult stage. Worms were 
mounted on agar pads with 1mM NaN3 in M9 buffer and imaged on a Zeiss LSM710 
confocal microscope. HRG-1-MCHERRY indicates rhodamine filter, and 

































Figure 24: mrp-5 Suppressor Reversion Assay 
Worms of the indicated strain: either (A) WT, (B) apb-3, (C) mrp-5, or (D) apb-3;mrp-5 
were maintained for one generation on NGM plates supplemented with 100 µM hemin in 
the agar, then bleached and their progeny were synchronized as L1s. Three of these 
synchronized progeny were moved to NGM plates seeded with HT115(DE3) for RNAi 
against the indicated genes. Once F1 treated with vector positive control reached gravid 
all treatments of that strain were analyzed by COPAS BioSort. For mrp-
5(ok2067/ok2067); apb-3(+/+) vector +200 µM hemin was used as the positive control. 
Data represents the averages of three technical replicates from two independent 
experiments. Indicated significant differences compared to the vector treatment were 
obtained by post-hoc multiple means comparisons utilizing Bonferroni correction *** p < 



































 The forward genetic screen described herein sought to uncover additional 
mechanisms involved in heme homeostasis by screening for bypass suppressors of mrp-5, 
an essential gene for heme export in C. elegans. Of the 32 suppressor mutants isolated, 
three of the strongest suppressors were mapped to distinct subunits of AP-3. The fact that 
AP-3 controls the trafficking of a large set of transmembrane proteins to several distinct 
organelles makes a mechanistic interpretation of the mode of suppression difficult. It is 
possible that suppression is due to the mistrafficking of one specific protein who’s 
trafficking is controlled by AP-3, or it could be a consequence of one of the broader 
phenotypes associated with loss of AP-3, such as defective biogenesis of lysosome 
related organelles.  
 The extra-intestinal accumulation of gut granular contents (Figure 21, “Results”) 
suggested a possible mechanism for bypass of mrp-5 deficiency (Figure 1). Material 
contained in gut granules localizes outside of the intestine70, raising the possibility that 
contents normally trafficking to gut granules (such as porphyrins) are secreted in AP-3 
subunit mutants. Previously, defective trafficking to yeast vacuoles or mammalian 
lysosomes has been shown to result in secretion of that compartment’s contents.70,104 If 
occurring though the basolateral membrane, this would functionally bypass regulated 
heme efflux by MRP-5. However, other glo mutants do not phenocopy mrp-5 suppression 
(Figure 22, “Results”). This could be due to the fact that glo-1 and pgp-2 mutants play a 
specific role at the site of gut granules important for their biogenesis, while AP-3 plays a 
much more general, upstream role in specifying cargo for delivery to gut granules and 
other compartments in the endolysosomal system.47 The lack of suppression by the 





granule biogenesis and distinct from glo-2 mediated trafficking is important for mrp-5 
suppression. Particularly problematic for this scenario (Figure 1) is the fact that 
autofluorescent material has been observed to accumulate extra-intestinally in glo-1, glo-
2 and pgp-2 mutants70,105 indicating that this glo phenotype is not correlated with mrp-5 
suppression, and that the basolateral secretion of gut granule contents (Figure 1) is 
unlikely. ZnMP treatment of additional glo mutants would be useful to gauge how 
equitable the trafficking phenotypes are between AP-3 subunit mutants and other glo 
mutants. 
 Based on the characterization of the dynamics of deficiency in AP-3 subunit 
mediated suppression of mrp-5 deficiency, we present a model for two plausible 
mechanisms of suppression (Figure 2).  
 The first hypothesis involves the regulated trafficking of heme containing vesicles 
from endosomes to gut granules (Figure 2A). The fact that mrp-5 phenotypes can be 
suppressed with dietary supplementation of heme suggests that there is a low affinity 
mechanism for the efflux of intestinal heme independent of mrp-5. ZnMP data indicate 
that porphyrins are accumulating in vesicles of the endolysosomal system, and that some 
of these vesicles may eventually fuse with gut granules (Figure 21, “Results”); it could be 
that the alternative, low affinity pathway is due to the fusion of a subset of heme 
containing vesicles with the basolateral membrane, resulting in heme efflux into the 
pseudocoelom. AP-3 subunit mutants, mis-specification of heme containing vesicles 
could result in an increase of the fusion of these vesicles with the basolateral membrane 
or other organelles. One inconsistency with this hypothesis is that RNAi against mrp-5 in 





“Results”). If increased efflux of heme-containing vesicles are responsible for 
suppression, then increased luminal heme should increase intestinal heme efflux and 
rescue growth. However the significance of this observation is unclear since loss of 
viability due to hrg-3 and hrg-7 RNAi in mrp-5; apb-3 double mutants can be rescued 
with heme (Figure 24D, “Results”). Another complication to this hypothesis is the fact 
that in the absence of mrp-5, loss of hrg-4 is lethal (Figure 24C-D), implying that in mrp-
5 mutants heme must be imported across the apical membrane into the cytosol. Cytosolic 
heme would then have to traverse the membrane of the vesicle. 
 The second hypothesis concerns the mistrafficking of a single transmembrane 
protein in AP-3 subunit mutants rather than a general defect in vesicular trafficking 
(Figure 2B). It is not clear how ZnMP and possibly other porphyrins are delivered to 
endolysosomal vesicles. One possibility is that endocytosis of luminal contents from the 
apical surface results in the accumulation of porphyrins at these sites. Another possibility 
is that an unidentified porphyrin exporter localizes in an AP-3 dependent manner to sites 
of ZnMP accumulation and acts to efflux porphyrins from the cytosol into these vesicles. 
Loss of AP-3 subunits could result in the mis-localization of this exporter to the plasma 
membrane, constituting a functional bypass of MRP-5. There is some precedent for this 
mis-sorting phenomenon. In mammalian cell culture models, AP-3 deficiency results in 
increased plasma membrane106 expression of lysosomal membrane proteins Lamp-1, 
Lamp-2, and CD63.93,106  
 Tissue-specific HRP reporters indicate in the intestine, loss of AP-3 subunits may 
increase heme availability in the secretory pathway (Figure 19, “Results”), implying that 





Combinatorial RNAi of mrp-5 and genes encoding AP-3 subunits have an additive effect 
(Figure 19, “Results”). This could be due to the fact that in mrp-5 mutants, increased 
ZnMP accumulation (Figure 8) implies higher intestinal heme content. Mis-localization 
of these increased heme stores would result in a higher content of heme mis-partitioned to 
the secretory pathway than with loss of AP-3 subunits alone. This is consistent with both 
hypotheses, as mis-partitioning of intestinal heme could occur through mis-trafficking of 
heme-containing vesicles or through mis-localization of a heme exporter. 
 A critical experiment to differentiate these two hypotheses would be treating 
wildtype, apb-3 mutants, and  apb-3; mrp-5 double mutants with an excess of 
exogenously provided substrate such as FITC-Dextran or TRITC-BSA. In wildtype 
worms, both of these substances are endocytosed and localize to gut granules and extra-
intestinally to coelomocytes.70 If basolateral secretion of endolysosomal contents is 
increased in suppressor mutants, these exogenous substrates would likely increase 
accumulation in coelomocytes. However, if heme is being trafficked through specific 
recognition of heme by an exporter, intestinal efflux of FITC-Dextran or TRITC-BSA 
may not be increased. 
 Validation of the hypothesis regarding mis-localization of an exporter would 
require identification of such a transporter, and would represent an important gain in our 
present understand of mechanisms underlying heme homeostasis, but its identification 
would be challenging. One approach would be to conduct a genetic screen for loss of 
mrp-5 suppression in AP-3 subunit mutants; the difficulty of this approach is highlighted 





7, hrg-3) or block intestinal entry (such as hrg-4) results in decreased viability (Figure 24, 
“Results) and would screen as a false positive for loss of mrp-5 suppression. 
 A systemic screening of trafficking components capable of mediating suppression 
of mrp-5 deficiency would significantly advance the current understanding of pathways 
important for this phenotype. Currently, loss of individual subunits AP-3 and AP-2 have 
been shown as being sufficient for mrp-5 suppression, an interesting observation given 
that there is evidence that loss of a single unit results in the formation of hemi-complexes 
which may retain some functional capacity.107,108 Addressing whether loss of other 
trafficking components ranging from specific trafficking functions71,109,110 to more 
ubiquitous components such as chc-1 or rab-5111 result in mrp-5 suppression would 
demonstrate what specific pathways, when disrupted, result this phenomenon and may 
help in ascertaining a molecular mechanism.  
 Although gut granules are autofluorescent, other markers can be used for their 
detection such as localization of glo-1::gfp or cdf-2::gfp; use of these additional markers 
would strengthen the assertion that ZnMP co-localization with autofluorescent organelles 
represents gut granule localization, and examination of the dynamics of these reporters 
when autofluorescence is not present, such as in AP-3 subunit mutants, may offer 
additional insights into trafficking dynamics in the absence of AP-3 function. 
 These hypotheses also make the assumption that intestinal AP-3 deficiency is 
responsible for mrp-5 suppression; but, this assertion is not demonstrated. Since the apm-
3 subunit is expressed ubiquitously93, there exists a possibility that mrp-5 suppression 
depends on an extra-intestinal mechanism. Additionally, apd-3 and apb-3 are reported to 





known.93 Specific knockdown of either isoform of these two subunits may yield novel 
findings regarding the role of these isoforms and potentially give insight into AP-3 
mediated suppression of mrp-5. 
























Figure 1: Potential suppression mechanism – global secretion of gut granules 
In mrp-5(ok2067/ok2067); apb-3(ok429/ok429) worms, autofluorescent material 
accumulates in the intestinal lumen, and it has been postulated this is due to secretion of 
gut granular contents. ZnMP treatment indicates that gut granules also accumulate heme 
(Figure 21, “Results”). If secreted gut granule contents, including heme, were secreted 
into the pseudocoelom out of the basolateral membrane, it could constitute a functional 




























Figure 2: Model for AP-3 mediated suppression of mrp-5 deficiency 
A model describing two potential mechanisms underlying the restoration of intestinal 
heme efflux in AP-3 subunit mutant, mrp-5 suppressor mutants. (A) Hypothesis 1: mis-
trafficking of heme containing vesicles results in an increase of the fusion of these 
vesicles with the basolateral membrane as well as other organelles, such as the ER. (B) 
Hypothesis 2: A heme exporter is normally localized to heme containing vesicles in the 
endo-lysosomal system in an AP-3 dependent manner; loss of AP-3 results in mis-
localization to the plasma membrane, constituting a bypass of mrp-5, as well as other 

































Appendix A: C. elegans Strains 
 
Strain Name Genotype Description Obtained by 
N2 WT Used as WT 
strain 
CGC 
Hawaiian (CB4856) WT WT, used as 
mapping strain 
CGC 








allele in the N2 
background  
VC1599 was 













was outcrossed to 
Hawaiian 9x times 










RB2257 apd-3(ok3058/ok3058) apd-3 mutant CGC 
JJ1271 glo-1(zu391)112 glo-1 mutant CGC 
 glo-2(zu445)112 glo-2 mutant CGC 
GH378 pgp-2(kx48)113 pgp-2 mutant CGC 
CB4845 unc-119(e2498) unc-119 mutant CGC 
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